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PREFACE
Within the last ten years, considerable interest has been aroused within the field of immunology by the discovery of macroglobulins with antibody
activity.

These molecules were first studied as the peculiar products of neo-

plastic disease states in man.

They gained somewhat more universal importance

when it was recognized that they were part of the primary antibody response
to a variety of antigens: macroglobulin (yM) antibodies preceded the appearance of 7S (yG) antibodies in the serum of immunized animals.

This transition

of antibody type in the serum has now been found in so many cases that it
appears that a primary response without this event is the exeception rather
than the rule.
The studies presented in this thesis began with an attempt to study a
primary antibody response in the spleen of the mouse. When it,was discovered
that yM and yG antibodies were involved, our efforts turned to studies on the
relative synthesis of these two antibodies by the spleen and then to experiments attempting to dissociate the two responses so that the cellular basis
might be better understood,

Finally, experiments in which spleen cells were

removed from immunized donors and were injected into X-irradiated recipients
were employed in attempts to assess the importance of anatomical continuity
and extracellular antigen to the yM-yG transition,
I am grateful to many of the scientists of The Rockefeller Institute
for their frequent guidance and discussions.
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In particular, I am in debt to

His encouragement, critical advice,
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ABSTRACT
14
The organ localization of intravenously administered C -labeled intact
S. adelaide was studied in mice. In the absence of circulating antibody, the
spleen had a higher specific activity than other organs studied.

The primary

antibody response to this antigen was then studied using a specific flagellar
immobilization assay.

Spleen homogenate supernatants exhibited two distinct

antibody peaks which were well separated in time.

The serum titer curve was

not detectably bimodal.
Sera and spleen homogenate supernatants were characterized by electrophoresis, ultracentrifugation, and treatment with 2-mercaptoethanol.

The pri-

mary antibody response was found to consist of the early, transient production
of yM antibodies followed.by the pro(iuction of yG antibodies.

This response

was quantitatively reducedlbut not qualitatively affected by the removal of
spleens from the mice before antigen injection.
Methotrexate and colchicine both exhibited differential effects on the
synthesis of yM and yG when they were administered during the antibody response.
With certain doses of each, the yG response seemed more susceptible to inhibition.

In all cases, however, the yG response recovered to near normal levels

after a delay.

Histological studies during a methotrexate inhibited response

showed that normal levels of yM could occur in the serum at a time when there
were no pyroninophilic blast cells or secondary nodules in the spleen. The
recovery of yG__was well correlated with the appearance of many haemocytoblasts
in the red pulp. At that time there were still no secondary nodules in the
white pulp.

yG antibodies recovered to nearly normal levels despite the fact

that maturation of the haemocytoblasts to mature plasma cells was inhibited.
A study was made of the transfer of spleen cells from primed animals
to homologous X-irradiated recipients. When spleen cells were taken from
immunized donors on day 2 or day 6 after injection of antigen, only yM antibody could be demonstrated in the recipients.

Spleen cells taken on day 8 or

day 10 after antigen produced mostly yG antibody in the recipients.
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A.)

yM and yG Antibodies

1.)

The unity and heterogeneity of antibodies
The micro-heterogeneity of proteins is a complex problem which cannot

properly be considered in this review; it has been well discussed by Colvin,
Smith, and Cook (1954).

A discussion of the difficulties inherent in relating

biological function to chemical and physical structure, however, is of import
to any study of different classes of antibodies.

Much confusion in antibody

classification stqms from early studies in the functions of antibodies and
from later attempts to postulate a unified theory of these phenomena, We
shall therefore begin with the historical background.
At the end of the nineteenth century, the major interest of immunology
was the description of phenomena involved in host defense against microorganisms.

Very little was known about mechanism or factors involved, and external

similarity was the sole criterion for relating one type of defense to another.
With each new phenomenon a new word was added to the vocabulary of host defense.
Antitoxins were first described by Emil von Behring, who found that animals
injected with sublethal doses of tetanus or diphtheria toxins produced serum
factors which could neutralize the toxins (von Behring and Kitasato, 1890).
These antitoxins were specific, and they would confer specific immunity when
transferred to a normal recipient,

Other serum factors, the bacteriolysins,

were soon discovered (Pfeiffer, 1894;; Pfeiffer and Friedberger, 1903).

When

bacteria were injected into the peritoneal cavities of previously immunized
guinea pigs, the bacteria were lysed, and this lysis was specific for the bao-:
teria used as antigen.

The activity could also be transferred to a non-immune

recipient with cell-free serum.

Although both functions were localized in serum,

there was no reason for assuming any relation between the two or means of characterizing either.

In 1895, Bordet distinguished the thermostabile lysin activity

from heat-labile serum bactericidal factors.

This gave one physical means of

classifying activity, but the multiplicity and interaction of these factors was
still confusing.
Within a few years, many of the other basic phenomena of immunology
were described:

Denys and Leclef (1895) described phagocytosis-promoting

opsonins, Kraus (1897) discovered precipitins, Bordet (1898) observed immune
hemolysis, and Bordet and Gengou (1901) discovered complement fixation.

Each

function was associated with a different hypothetical cause: antitoxin, precipitin, lysin, agglutinin, amboceptor, opsonin, etc.;,each term was assumed
to represent a different serum factor.

There was often a lack of parallelism
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on the titration of different activities, and such evidence supported theories
of multiple factors.
On the other hand, evidence relating these functions quantitatively was
gradually accumulating.

Doerr and Russ (1909) showed a quantitative relation-

ship between the precipitin content of an antiserum and its anaphylactic sensitizing properties,

Felton and Bailey (19268) found that the water-insoluble

protein from Type I antipneumococcus serum agglutinated the specific cocci,
protected mice, gave positive precipitin tests, fixed complement, and stimulated
phagocytosis. All the protective antibody was precipitated by the specific polysaccharide (Felton and Bailey, 1926 b) and could be recovered from the precipitate (Felton, 1932).

Heidelberger and Kabat (1936) studied the type-specific

agglutinins and precipitins in the horse.

The amount of each by weight was

identical, and the removal of one resulted in the quantitative removal of the
other.

Similar quantitative studies by Chow and Wu (1937) proved the identity

of the precipitating, anaphylactic sensitizing and complement-fixing activities
in rabbit antisera.

The weight of this and similar evidence led to the view

that one antibody could perform all of the above functions. As stated by
Zinsser (1931) this "unitarian hypothesis" follows:
By such a conception of antibodies, we do not imply that a complex cell like,
for instance, a typhoid bacillus can only give rise to one variety of antibody...
we do mean that, were we working with a single antigen in a pure state, one
variety of antibody would be produced. This would be present in the form of
a serum constituent specifically capable of uniting with the antigen...The resultant reactions which may be observed with this sensitized antigen (agglutination, precipitation, bactericidal phenomena, opsonization, or sensitizing effect
on the anaphylactic sense) would be determined, not by differences in the nature
of the antibodies with which the antigen had united, but rather in the co-operating substances (alexin, leucocytes, tissue-cells) and by the environmental conditions under which the observations are made.
We generally accept today the theory that the same antibody can perform
more than one function.

But we also know that an antigen ofte^, perhaps always,

gives rise to different kinds of antibodies. For instance, the Rh antigen gives
rise to two different antibodies.
one can agglutinate them.

Both combine with red blood cells, but only

The second is called an "incomplete" antibody.

Pre-

sumably, both antibodies are produced by the same antigen (Race and Sanger,
1954).

As another example, conjugated antigens are known to evoke antibodies

with different specificities:

some are directed against the haptene, some

against the protein carrier, and some against both haptene and protein together
(Landsteiner, 1945).

Does this disprove the unitarian hypothesis?
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Perhaps, as Zinsser points out in the above quotation, what we have
been calling an antigen is really a complex body containing more than one
antigen - i.e., a conjugated protein is really two antigens, the carrier and
the haptene.

But among antibodies directed only against the haptenic group

there are molecules with different affinities for different parts of the
haptene (Landsteiner and van der Scheer, 1938).

More recent studies have

shown that antibodies directed against a simple dextran molecule are quite
heterogeneous with respect to the sizes of their combining sites.(Schlossman
and Kabat, 1962). In fact, if the concept of "one antigen-one antibody" is
to be upheld, we must specify smaller and smaller molecular groupings as antigenic determinants.

The concept is then hardly testable and its truth is not

an important question here. What is important is that we never work with
"pure antigens," and all antibody responses are more or less heterogeneous
(Smith and Jager, 1952; Boyd 1956).

The amount of heterogeneity ascribed to

an antiserum is often a direct function of the number of criteria by which it
has been examined.

In general, antibody activities are separated by either

immunologically specific methods or by physico-chemical, non-specific methods.
Specific methods for separating antibodies depend on the formation of
antigen-antibody complexes. For such methods to be useful, one must be able
to isolate the complex and remove non-specifically bound contaminants, dissociate the complex, and eventually separate the released antigen from the
antibody.

Non-specific methods, on the other hand, depend on physicochemical

differences among the plasma proteins and among antibodies themselves.

These

take advantage of such properties as solubility, electrophoretic mobility, and
molecular weight.

The many variations of specific and non-specific methods

have been well reviewed by Cann (1958) and will not concern us here. What
might be pointed out, however, is the inconclusiveness of any one separation,
specific or non-specific, in terms of the functional or molecular properties
of the antibodies isolated.

Specific methods may separate antibodies which

still differ in combining affinities or physical characteristics.

Non-specific

isolates may be heterogeneous by other non-specific techniques, and they may
or may not separate functions.

Later in this review, we shall speak of the

classification of antibodies as yG or yM.

Perhaps it is important here to

illustrate more fully the limitations of such classifications and the possible
heterogeneity of the antibodies in each class.
a) That non-specific isolates may be heterogeneous by other non-specific
criteria:

it is not at all surprising that serum fractions isolated by one
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physico-chemical method should still be heterogeneous.

For example, one common

serum fractionation is the ethanol procedure as defined by Cohn and his associates (Cohn et al., 1940).

When human serum is treated with ethanol under care-

fully controlled conditions, four fractions of gamma globulin can be isolated:
y_-globulin, 11-1,2, II-3, and y -globulin. Each fraction has a different mean
1
z
isoelectric point and each migrates as a single boundary in an electric field.
If examined by reversible boundary spreading, however, each fraction is electrophoretically heterogeneous (Jager et al., 1948).

In addition, each frac-

tion has been found to be impure according to sedimentation, solubility, and
immunological criteria (Cohn, Deutsch, and Wetter, 1950).

Also, y-globulins

have been- shown to exhibit almost continuous distributions when examined by
various physico-chemical parameters.

Thus, Williams et al. (1952) were unable

to resolve horse y-globulin into fractions having discrete sedimentation|coefficients. And bovine y-globulin has been separated into eight fractions, of
different mean mobilities when examined by reversible boundary-spreading (Cann,
Brown, and Kirkwood, 1949).

In fact, the designation of fractions isolated

by any non-specific method is largely arbitrary and must be employed with reservation. As Cann (1958) has pointed out:
The serum globulins are very heterogeneous with respect to both biological and
physico-chemical criteria. Indeed, the globulin fraction contains so many mole
cules differing only slightly from one to another in electrophoretic mobility
that it might well be considered as possessing a continuous, rather than a discrete distribution of mobilities, as often supposed. The various maxima in
the distribution can be designated arbitrarily asOC, J5-, and y-globulin.
b)

That non-specific separation may isolate functional activities;

despite the broad heterogeneity of y-globulins, non-specific methods may, at
times, purify certain antibody activities.

For instance, one activity may be

separated from another by the preferential inactivation of the latter.

Thus,

Forssman (1922) reported that when anticorpuscle serum was mixed with ether
and heated at 56 C the hemolysin activity was destroyed while the agglutinin
activity was unaffected.
complement.

This, of course, depends on the heat-lability of

But true separations of activity have also been achieved.

Type

specific horse anti-pneumococcus antibodies are euglobulins (Felton, 1928),
while horse diphtheria antitoxins are pseudoglobulins (Pappenheimer et ^al''. ,
1940).

Deutsch and his associates (Deutsch et al., 1947) found that isohemagg-

lutinins and typhoid 0 agglutinins were concentrated in the y-globulins while
diphtheria antitoxins were concentrated in the y-globulins.

Kuhns (1954)

found that skin-sensitizing diphtheric antitoxin migrated as a y-globulin,
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whereas

nonsensitizing, precipitatij|g antitoxin was a y-globulin.

Also,

complete Rh saline,;^ agglutinins, cold agglutinins, heterophile antibodies, and
others are associated with 19S y-globulins separable by centrifugation
(Franklin, 1962).
c) That non-specific isolates may be functionally heterogeneous:
instead of separating functions non-specifically, it is more usual to find the
same function performed by antibodies having a broad range of physico-chemical
characteristics.

Deutsch et al. (1947) found typhoid H agglutinins and anti-

bodies against influenza virus in both y

and y
J.

fractions. Antibodies with

at

both 19S and 7S sedimentation coefficients have been found in responses to
S. typhosa, T

phage, diphtheria toxoid, human serum albumin, bovine gamma

globulin, and keyhole limpet hemocyanin (Bauer, Mathies, and Stavitsky, 1963).
Also, incomplete Rh antibodies have been found broadly distributed throughout
the serum globulins or at times having a bimodal distribution (Cann et al.,
1952).
^) That specific isolates may be heterogeneous;

finally it is worth

noting that specifically isolated antibodies may not only have varying physicochemical properties, but also

that

they

may be functionally heterogeneous.

Preparations containing nearly 100% precipitable antibodies have been shown
to consist of molecules with a wide range of affinity for the antigen.involved
(Karush, 1959).
The cause of this variation among antibodies
tion of great interest in immunology.

has proven to be a ques-

Some variation certainly results from

the multiplicity of antigenic determinants on any one antigen.
not the entire answer.

But this is

For instance, much investigation during the 1930*s..

was concerned with the responses of different species to the same antigen.
Heidelberger and Pedersen (1937) found that type specific antipneumococcal
antibodies in the horse had sedimentation coefficients of 18.4 while those in
the' rabbit were mainly 7S. Kabat (1939) extended this work to show that antipneumococcal antibodies from cow, horse, and pig had molecular weights of
nearly one million; antibodies from human, rabbit and monkey had the same
molecular weights as normal y-globulin (160,000).

Goodner and Horsfall (1936)

divided antibodies on the basis of their ability to fix complement:, thus,
rabbit, rat, guinea pig, and sheep antipneumococcal antibodies were complement
fixing, while horse, human, canine, mouse, cat, and goat antibodies did not
fix complement.

Horsfall and his coworkers also claimed that sera from diff-

erent species could have different therapeutic value (Horsfall et al., 1937).
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Another focus of interest was the antibody response to different antigens in the same animal. We have already mentioned that anti-pneumococcal antibodies and diphtheria anti-toxins in the horse had different solubility properties.

Van der Scheer, Wyckoff, and Clark (1940) identified a "T component" in

horse serum which migrated electrophoretically between and y and
Antibody responses fell into three groups:

1) elevated y, no T,

globulins.
2) elevated T,

normal y, and 3) both classes elevated. In studying sera from 15 horses hyperimmunized against bacterial antigens, these authors found that the responses
to each antigen characteristically fell into one of these three groupings.
Experiments on the role of species differences or antigenic differences
did not establish any universal principle regarding antibody variation; such
experiments often added to pre-existing confusion and sometimes could not be
confirmed.

Some sense was made out of chaos by Porter and his associates.

These authors used partition chromatography on celite to separate the antiovalbumin activities in immunized rabbits (Porter, 1955).

They found that

after repeated intravenous immunizations for three weeks, the antibody produced was located in the slowly moving chromatographic fractions. After a
secondary schedule of immunizations two months later, the antibodies were
found in faster chromatographic fractions, Antibodies to type III pneumococcus
and influenza virus were also separable chromatographically and showed the
same pattern of response (Humphrey and Porter, 1956).

When two antigens were

given simultaneously, the response to each was independent of the other.
After a subcutaneous injection of antigen with adjuvant, a granuloma was
formed.

This granuloma could be shown to be producing at leagt 807o of the

total antibody (Askonas and Humphrey, 1955).

Unlike the antibody appearing

after intravenous immunization, antibody from granulomas was found in both
the fast and slow, moving chromatographic fractions within a few weeks and no
change was observed over a period of months.

This observation led these

authors to suggest that perhaps a constant site of antibody formation was
associated with the production of a constant type of antibody.

The change

in type of antibody after an intravenous injection might then be a reflection
of a change in site of production.

These experiments were important in stress-

ing two things: 1) the possiblity of a bimodal response, and 2) the critical
role of route of antigen administration and stage of immunization.

We shall

review experiments detailing similar responses in the following section.
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There can be no doubt that the y-globulins are a heterogeneous group
of proteins. . It is unlikely that the heterogeneity is caused by the difference
between antibody y-globulin and y-globulin with no antibody activity,

In fact,

many investigators feel that all y-globulin production is in response to some
sort of antigenic stimulus (Gustafsson and Laurell, 1958; Svehag, 1964 b). Also,
in view of the differences in size, mobility, and chemical composition among
antibodies, it seems unlikely that the heterogeneity is solely the result of
differing specificities.

Recent results on the structure of antibodies, how-

ever, support the idea that within any class or type of antibody the heterogeneity is caused by differences in the number and structure of subunit polypeptide chains, Thus, mammalian yG globulins have been separated by reduction
and subsequent starch gel electrophoresis in 8M urea into two kinds of polypeptide chains: light (L) and heavy (H) chains (Edelman and Poulik, 1961),
The H chains apparently contain the antigenic differences between the human
antibody types y., y

, and y

(Edelman and Benacerraf, 1962).

On the other

hand, the heterogeneity of the molecules in any classification according to
size or immunoeMctrophoretic type appears to depend on differences In their
content of L chains. Upon starch gel electrophoresis in urea, "normal" y-globulin showed a slow band corresponding to the H chains and a faster smear of L
chain components.

Specifically purified antihaptene antibodies, however,

showed sharp bands of distinctive mobility in the L chain region, and the
pattern of these bands was characteristic for each antibody specificity
(Edelman et al., 1961; Edelman, Benacerraf, and Ovary, 1963),

Thus, specific

isolation can separate antibodies of remarkable structural similarity.

Even

antibodies directed against a simple chemical grouping, however, have a range
of different structures (Benacerraf, Merryman, and Binaghi, 1964).

Also,

despite the lack of major differences between pooled and specifically isolated
y-globulins, there is some evidence that small chemical and antigenic differences do exist (Gurevich, Gubernieva, and Miasbedova, 1961; Kunkel, Mannik,
and Williams, 1963).

So perhaps more than one antibody type is always involved

in any antigen-antibody reaction.
Talmage (1959) has suggested that the heterogeneity of y-globulins enables a multiple reaction theory to account for antibody specificity. According to this theory, antigens combine with pre-existing globulins for which theJ?
have some degree of affinity.

An antibody response is the selective increase

in production of those natural globulins having a high affinity for the injected
antigen but overlapping specificities.

This theory successfully avoids the
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question of whether one antibody is formed in response to a single antigenic
determinant.

Talmage also says that "in a mixture of a large number of differ-

ent globulin molecules, the dominant reactivity will be that common to the
largest number of molecules present." This conforms to the general opinion
that the functional manifestation of an antigen-antibody interaction varies
with the environmental test conditions.
The causes of heterogeneity among antibody globulins remain unresolved.
Some of the factors affecting the yM and yG responses will be discussed later
in this paper.

One should remember, however, that yM and yG groupings result

from a number of arbitrary criteria for differentiating structures and functions,
and that in both cases we are dealing with the average behavior of groups of
widely varying protein molecules.

There no doubt will be many subdivisions and

exceptions to these groups as methods become more sophisticated.
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2.)

The sequential production of yM and yG and some exceptions to the rule
Porter and his associates were not the first to show that the type of

antibody produced might vary with the stage of immunizations.

Experiments study-

ing the response in the horse to pneumococci had associated the early antibody
produced with an electrophoretic component not present in normal serum: the "T
component," migrating between the y and ^ peaks.

When horses were repeatedly

immunized over long periods of time, there were some indications that an antibody of a lower mobility appeared (Tiselius and Kabat, 1939).

Sedimentation

studies came to similar conclusions: that antipneumococcal antibodies in the
horse were of the macroglobulin 19S class, but that after prolonged periods of
immunization antibodies with sedimentation constants of 7S, lOS, and 12S appeared
(Kabat, 1939).

No thorough studies were done on the characteristics of each of

these antibodies or of the factors affecting their appearance, and many of the
results obtained seemed mutually inconsistent.

For instance, Kekwick and Record

(1941) found that "the immediate reaction in the horse [to diphtheria toxoid] is
the production of the y-globulin antitoxin. As further injections are given
increasing quantities of ^-globulin antitoxin are formed..."
from that found by Tiselius and Kabat,

This sequence differs

In support of Tiselius and Kabat, van der

Scheer found that early antipneumococcal antibody in the horse migrated between
the y and B peaks and was later replaced by pure y-globulin, but he in turn could
find no evidence for activity in a light 7S component in horses immunized for as
long as ten years (van der Scheer, Lagsdin, and Wyckoff, 1941).
results remained largely unresolved.

These different

While there was much evidence that differ-

ences in physical properties of antibodies existed, there was no consistent correlation of these properties with species or antigenic differences, stage or route
of immunization, or particular manifestations of antibody activity.
At the time of Porter's work, Taliaferro, Talmage, Stelos, and their
associates independently studied the antibody response in the rabbit to repeated
injections of sheep erythrocytes.

They found that the Forssman hemolytic ac-

tivity of an antiserum declined as immunization proceeded.

At the same time,

however, the Forssman combining capacity was constant (Talmage, Freter, and
Taliaferro, 1956 a). This suggested the possibility of a sequential production
of two different antibodies having different hemolytic efficiencies. This
assumption was proved correct by the subsequent centrifugal separation of two
antibodies with closely related specificities:

the heavier of the antibodies

was 100 times more effective at hemolysis (Talmage et al., 1956 b). The antibodies could be separated by electrophoresis, with the hemolytic antibody

11
migrating in the y

region while the combining antibody was found in the y

region (Stelos and Talmage, 1957).

Also, the two antibodies differed in rates

of metabolic decay after passive transfer (Taliaferro and Talmage, 1956) and
in the kinetics of the hemolysis reaction (Weinrach and Talmage, 1958),

Whereas

Porter had been unable to correlate the chromatographic behavior with other propeties of the molecules, these authors convincingly demonstrated a transition
from early, short-lived, highly hemolytic, 19S y -globulin antibodies with high
anionic binding capacity to late, long-lived, 73 y-globulin antibodies with
much less hemolytic activity and low anionic binding capacity.

These results

were extended to includes number of different antigens, and similar sequences
were found with one exception:

human type A red blood cells stimulated only

the 19S y -antibodies (Stelos, 1958; Stelos and Taliaferro, 1959; Stelos,
Taliaferro, and D'Alesandro, 1961).
In the above experiments and the concurrent work of Porter, antibodies
were produced in response to multiple immunizations.

In fact, Porter believed

that the change in antibody distribution was a direct response to the repeated
antigenic stimuli and not caused simply by the passage of time.

Bauer and

Stavitsky (1961), however, soon found identical sequences of antibodies after
single inJectioniS of a variety of particulate and soluble antigens. These
authors also differentiated between the two types of antibody by. incubating
them with 2-mercaptoethanol;

sulfhydryl compounds dissociated macroglobulins

into inactive subunits, but had no effect on 7S globulin activity (Deutsch and
Morton, 1957; Glenchur, Zinneman, and Briggs, 1958).
The chromatographic, electrophoretic and ultracentrifugal behavior of
these types of antibody, as well as the preferential inactivation of the
macroglobulins by sulfhydryl compounds, have now been used to study the antibody response in many species and with a variety of different antigens. The
two classes of antibody globulins defined by these techniques have been called
yM and yG.

The general nature of an antibody response has been the same in al-

most all cases: after an induction period of varying Ifength during which no
antibody can be demonstrated, the initial activity detected is associated with
yM globulins.
few days.

The amount of yM increases exponentially to reach a peak in a

In most cases, however, production of yM ceases shortly after its

highest titers are reached, and the amount of serum yM declines at a characteristic decay rate. At approximately the time yM peak titers are reached, or
shortly thereafter, yG appears in the serum and increases exponentially at a
somewhat slower rate that yM.

Within a month after the initial injection, yG
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has usually totally replaced yM in the serum.

The amount of serum yG may then

remain fairly constant or gradually decline over a period of months.
Much of the work detailing this sequence of events has been summarized
in Table I.

The range in experimental animals, the variety of antigens, the

different routes of antigen administration, and" the various kinds of titrations
used all give evidence of the importance of this phenomenon.
There are, of course, exceptions to this sequence.
yG antibody has arisen without any preceding yM response.

In a few cases,
Thus, although no

kinetic studies were done, Fahey and Humphrey (1962) claimed that the earliest
antibodies in mice to spider crab hemocyanin and pneumococcal polysaccharide
SS III were 6.5S y-globulins.

Also, in studies in guinea pigs with two

different viruses, both live and inactivated, complement fixing antibodies were
entirely of the yG type whereas virus neutralizing activity followed the expected yM-yG sequence (Graves, Cowan, and Trautman, 1964; Bellanti et al,, 1965).
The possibility that certain antigens may favor a yG response is raised by the
work of Ada et al. (1963),

These authors found that soluble flagellin was

100,000 times less effective than particulate flagella in causing a yM primary
response.

Their results are not clear, however, as to whether this difference

is caused by the difference in physical state of the antigens or by the greater
comtamination of the particulate flagella with traces of somatic 0 antigen.
A more common exception to the yM-yG sequence is the exclusive production of yM with no appearance of yG activity.

This is often the case with

certain kinds of antigens. Thus, agglutinin and hemolysin titers in rabbit antimouse erythrocyte sera remained in y-globulin fractions even after .eight injectioiB (Lee, Takahashi, and Davidsohn, 1960),

Bauer and Stavitsky (1961)

found that yG antibodies to Salmonella 0 antigen in the rabbit were not synthesized even following three injections of intact organisms. Also, no JQ
activity could be found to typhoid 0 antigen in sera from 150 different
immunized humans (LoSpalluto et al., 1962).
a critical factor.

The amount of antigen may also be

With some antigens known to produce a normal yM*-yG sequence,

reduction of the antigen dosage below a certain level results in a transitory
yM antibody response with no subsequent yG production (Uhr and Finkelstein, 1963;
Svehag and Mandel, 1964 a).

Perhaps either the type of antigen or the dosage

involved causes certain antibodies and related substance^ in man (Rh saline
complete agglutinins, heterophile agglutinins, and cold afgglutinins among others)
to be found consistently in the .yM fraction.

In a like manner, the background
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antibody activity found in sera from "normal", unstimulated animals (the so-called
"natural antibody") has been found to be yM in a number of cases (Rowley and
Turner, 1964; Svehag, 1964 b; Michael and Rosen, 1963).
The genetic constitution of the host may also play a role in the relative production of either yM or yG. For instance, persons of blood group 0 produce relatively more isohemagglutinins of the 7S type than persons of blood groups
A or B (Fudenberg, Kunkel, and Franklin, 1959).

When rheumatoid factor was pre-

sent in a patient, however, the 7S type isohemagglutinins were reduced below
normal (Rawson, Abelson, and McCarty, 1961),

Kim et al. (1964 b) have found

that host-associated factors may. also alter the type of response:

in the pri-

mary response to MSP8 actinophage, piglets which were both germ-free and colostrumdeprived produced only yM antibody, whereas conventional colostrum-deprived animals produced both yM and yG.

In addition, species differences may be important.

In most species, "hyperimmunized" animals manufacture antibody which is totally
yG.

In one case, however, Franek has found that antibodies in the pig hyper-

immunized with Brucella suis remained mostly in the yM fraction (Franek, Jouja,
and Kostka, 1962).

Some differences are correlated with the position of a species

on an evolutionary scale.

In non-mammalian vertebrates the slowly sedimenting

antibody activity characteristically differs from the yG in mammals by being susceptible to inactivation by sulfhydryl reagents.

This has been shown to be the

case in the frog and goldfish (Uhr et al,, 1962 b), in the turtle (Grey, 1963 a),
and possibly in the mallard duck (Grey, 1963 b), yG antibody in the chicken
may also be more susceptible to sulfhydryl inactivation than mammalian yG
(Benedict, Brown, and Hersh, 1963 b). The yM response in these animals seems
to be of greater importance than in mammals, or at least of greater duration,
and this was particularly true in the turtle.

Studies in cold blooded verte-

brates indicate that in, more primitive animals the yG response; does not occur
at all. The antibody produced in response to T

phage in the elasmobranch

guitarfish was sensitive to 2-mercaptoethanol and had a 19S sedimentation coefficient (Good and Papermaster, 1964).

Both the primary and secondary res-

ponses to Brucella in the California lamprey, paddlefish, and gar consisted of
14-15S antibodies without the subsequent appearance of lighter-weight antibody
(Ashbach et al,, 1964).

Although evidence in this area is very sparce, „such

findings have led to the suggestion that the yM response is a primitive protective device found early on the evolutionary scale, while the yG response is
a later development in the phylogeny of adaptive immunity.
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To find a possible selective advantage of the yG over the yM response,
one need only look at the most notable exception to the rule of yM-yG transition;
the secondary response.

The high levels of antibody activity common to the

secondary or anamnestic response are almost entirely of the yG type, and there
is no comparable preceding yM response. Also, only a primary yG response can
stimulate the lasting immunological memory essential for a typical secondary
response.

Recent work has shown that secondary injections given within a short

period after the primary response can stimulate asecondary response of the yM type.
Although this response is smaller in absolute titers than the secondary yG,
Svehag and Mandel (1964 b) feel that the relative increase in each case is the
same.

The yM immunological memory is short-lived, however, and it was non-exist-

ent within two weeks after primary immunization in all responses examined thus
far.

There has been a recent report (Nossal et al., 1964) that there may be long

term memory in yM production in at least one case, but the details of this work
have not yet been published.

Long-lasting immunological memory and the rapid

production of large amounts of circulating antibody upon second contact is of
selective advantage to survival, and the above findings support the theory that
the yG response is a relatively recent evolutionary development.
We have seen that the chemical nature of the antigen, the dosage, the
genetic nature and species of the host, and the stage in immunization all may
alter the transition of yM to yG antibody.

There has been a recent suggestion

that the route of immunization may affect this sequence (Shulman, Hubler, and
Witebsky, 1964),

After an intravenous injection of human serum albumin into

rabbits, the initial yM response was replaced by yG within 20 days; when antigen
was injected intradermally with Freund's adjuvant, however, the yM response
was bimodal and was still detectable five months after immunization.

On the

other hand, Svehag and Mandel (1964 b) could detect no difference in response
when rabbits were injected intravenously, intraperitoneally, or in the hind
foot pad with poliovirus.

The fact that complete Freund's adjuvant was used

in the former experiment and live antigen was used in the latter may make both
of these experiments somewhat special cases,
A number of findings emphasize the important role of antigen in the yM-yG
response;

1) the minimal dose requirement for induction of yM antibody is much

less than that for yG, perhaps as much as 50 times less, 2) with low doses of
antigen, yM synthesis ceases abruptly at about 4-5 (jlays after immunization, while
with higher antigen doses yM synthesis may continue for about two weeks (Svehag
and Mandal, 1964 a)„ 3) the cessation of yM synthesis on days 4-5 does not appear
to be due to loss of viability of cells and may be caused by insufficient antigen
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(Uhr and Finkelstein, 1963; Uhr,^. 1964; Finkelstein and Uhr, 1964).

With these

findings in mind, we might consider the exceptions to the yM-yG transition we
have just discussed and reinquire into the role of antigen.

One question of

interest is why certain antigens evoke activity in the yM fraction for long
periods of time which is not followed by yG. As yet, this, behavior has not
been correlated with any physical state oi* chemical feature of the antigens.
What may be common to these antigens is the manner in which they are removed
by the reticuloendothelial system and digested within phagocytic cells. The
prolonged yM response to red blood cells and bacterial somatic antigens may
be due to the slow degradation of these antigens by phagocytic cells and release to antibody forming cells.

"Natural antibody" complexing with these anti-

gens might cause increased sequestration in the liver, an organ which does not
form antibody (Benacerraf et al., 1959).

In either case, if the antigen for

some reason contacted potential antibody forming cells in low doses over a long
period of time, one would expect a prolonged yM response but no yG because of its
higher threshold.

If such was th© case, perhaps larger antigen loads might pre-

sent enough antigen to th© producing cells to stimulate a yG response, Recent
studies supporting ethis idea have shown that with repetitive stimuli and/or
massive antigen doses good yG responses can be obtained to both red blood cells
(Davidsohn et al., 1962) and to bacterial somatic antigens (Pike and Schulze,
1964; Weidanz, Jackson, and Landy, 1964).

As another example, the bimodal yM

response reported by Shulman et al, (1964) may have been caused by the slow continuous release of antigen from th© adjuvant depot.

This might stimulate a pro-

longed yM response without causing any significant secondary yG.

Perhaps the

reason that antibodies such as heterophile agglutinins and cold agglutinins are
associated with the yM fraction Is the gradual release of the antigens involved
in amounts insufficient to stimulate yG,

The lower threshold of the yM response

might also be the cause of the association of "natural antibodies" with yM and
not yG; perhaps these antibodies are formed in response to jfRinute quantities
of antigen derived from foods or minor infections.

There have been suggestions

that the particulate nature of an antigen favors the yM response.

Though this

remains to be proven, the only common characteristic of particulate antigens
would seem to be the way they .are localised, phagocytized, or otherwise handled
by the reticuloendothelial system.
Before finishing this section, a few words of caution might be said about
evaluating studies dealing with the yM-yG transition.

Firstly, one should be

attentive to the methods for determining antibody titers. We have already noted
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that yM molecules have a much greater hemolytic efficiency than yG (Weinrach and
Talmage, 1958).

Other studies have shown that the tanned cell hemagglutination

method detects yM antibodies out of proportion to its ability to detect yG (as
compared to spontaneous precipitation of labelled antigen or ammonium sulfate
precipitation of bound antigen),

This conclusion has' been reached after thorough

work in both the chicken (Benedict, Hersh, and Larson, 1963; Dreesman et al.,
1965) and in the rabbit (Freter, 1957; Greenbury, Moore, and Nunn, 1963; Shulman
et al., 1964; Grey, 1964).

Such findings question the desirability of using

hemagglutination or hemolysis titrations to evaluate yM and yG responses. To
mention still another possible functional difference of importance in determining
titers of yM and yG, there has been a recent report that yM in contrast to yG
diphtheria antitoxin fails to neutralize diphtheria toxin in vivo (Robbins, 1965),
Secondly, quantitative studies of both types of antibodies should be
carried out over long periods of time to get a true picture of the response.
This is especially true in studies of the selective repression of either yM or
yG,

Comparisons of titers at the same time interval after the injection of an-

tigen seldom give a true picture of the magnitude or course of a response.

Vari-

ous experimental manipulations may lengthen the induction period of a particular
antibody type and displace the titer curve.

It would be interesting to know, for

instance, whether the different responses to flagella and flagellin found by
Ada et al. (1963) were as specific as they seemed or whether the induction time
for the flagellin response was simply lengthened until that antigen was removed
from the circulation.

One cannot conclude that an antibody response has been

destroyed simply because no antibody of that type is found on the day of its
normal peak titer.

There is a meaningful difference between permanent inhibi-

tion and delay, and experimental conclusions should be critically evaluated in
this light.
In this discussion', we have concentrated on the transition during the primary antibody response of yM to yG type antibodies.

There are many areas less

germane to this thesis which are associated with studies on yM and yG.

Such

topics include the chemical and physical properties of both immunoglobulins,
studies on their digestion or dissociation and their sub-chain structure, the
respective functions cf yM and yG and how they differ, antibody activity in the
yA class of immunoglobulins 5 and proteins in disease states related to either
type, A review of any one of these could cover as many pages as are already ;
written here, A number of excellent reviews covering these topics have appeared
recently, and the reader is referred to them (Kunkel, 1960; Franklin, 1964; Cohen
and Porter, 1964; Tomasi, 1965; Franklin and Lowenstein, 1964).
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B.) The Role of the Spleen in Antibody Formation
It is generally accepted that following an intravenous injection of antigen,
especially a particulate antigen, the spleen is a major source of antibodies.
This has been tacitly assumed in much of the work to be presented in this thesis:

antibody found in spleen homogenates is assumed to have been produced in the spleen,
and histological events in the spleen are taken to reflect antibody formation.
A consideration of the historical evidence implicating the spleen in the production of antibodies is therefore important to the results presented later. This
evidence is derived from various areas of research, and the discussion of the
following section has been divided according to these areas.
1.) Antibody activity in splenic extracts; The work of Paul Ehrlich toward the
end of the nineteenth century stimulated great interest in antibodies and the
organs producing them. At the same time that the basic phenomena of immunology
were being detailed in blood serum, the other body "humors" were being investigated.

For instance, the soluble portions of organs were examined by grinding

the organs with sand and examining the centrifugal supernatants.

Pfeiffer and

Marx (1898), Wasserman (1898), and Deutsch (1899) had all been able to find
antibody in soluble extracts of spleens.

These experiments suggested that the

spleen might be involved in antibody formation.

There was the possibility, how-

ever, that antibody formed elsewhere might accumulate in an organ by leakage
from blood vessels. Knowledge of the role of the spleen in antibody formation
awaited more direct evidence.
2.)

The effect of splenectomy;

Because the removal of the spleen was not lethal

to the animal involved, this device was used to study the importance of the spleen
more directly.

In 1892, Tizzoni and Cattani showed that splenectomized rabbits

failed to develop immunity to tetanus. With the advent of in vitro functional
tests to measure amount of antibody, other investigators restudied this effect
of splenectomy on antibody production.

Rath (1899) found a decrease in agglu-

tinin production after splenectomy, Luckhardt and Becht (1911) observed a similar reduction of hemolysin production in dogs, and Hektoen (1920) extended these
observations to the rat and rabbit,

Hektoen also found that injections of human

blood intraperitoneally into splenectomized rabbits yielded good titers of agglutinins but no precipitins.

This suggested that the spleen might play a special

role in the formation of certain types of antibody.

Despite such findings many

persons were unable to show consistently that removal of the spleen decreased
subsequent antibody formation,

Motohashi (1922) found that one source of con-

fusion was the amount of antigen injected.

With large doses,of antigen given
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intravenously, the effect of the spleen removal was masked and titers were as
high as normal. With smaller doses there was no doubt that removal of the spleen
decreased subsequent antibody titers. Much of this early work on the function
of the spleen in antibody formation has been reviewed by Krumbhaar (1926), Topley
/
(1930), and Jaffe (1931),
The effect of splenectomy has been more recently studied by Rowley (1950 a,b).
He confirmed Motohashi's finding that the decrease in serum antibody titers was
only dramatic when small doses of antigen were used.

In fact, when antigen doses

were small enough perhaps all antibody production occurred in the spleen - i.e.,
splenectomy after the primary response abolished the capacity for any subsequent
secondary response. Also, the route of immunization was very important.

If

the injection was intraperitoneal or intraportal the antibody response was the
same in splenectomized rats as in intact rats.

Despite reports in the early

literature that hypertrophy of other reticuloendothelial tissue would rapidly
compensate for the removal of the spleen, Rowley found that the antibody response
was the same whether antigen was given one hour or six months post-operatlvely,
Wolfe et al. (1950) extended this work to study precipitin formation in chickens,
and they found results similar to studies in mammals.
In a series of lengthy papers, Taliaferro and Taliaferro (1950; 1951; 1952)
investigated the kinetics of the hemolysin response in intact and splenctomized
rabbits.

Comparing the antibody curves in both animals they concluded that the

spleen forms most of the antibody during the initial rise in titer and then abruptly stops forming antibody at or about peak titer.

Splenectomy at the time of

peak titer did not affect the rate of decrease in serum titer afterwards.

Splenic

antibody apparently disappeared due to normal metabclllc degradation until the
continuing level of antibody from non-splenic sources was reached. After that
time, splenectomized and intact rabbits had identical titers and identical rates
of antibody decay.

With multiple antigen injections, not only was the spleen

relatively less important, but also hemolysin titers rose much higher in splenectomized than in intact animals.

This might have been caused by hypertrophy of

other reticuloendothelial tissue in the absence of the spleen, or by greater
contact of other tissues with antigen in the absence of a spleen which could
capture most of the antigen but produce only limited amounts of antibody.
These authors also concluded that the spleen played the same role after a second injection of antigen (i.e,, the production of the initial antibody titers)
as it did after a first injection.
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3.)

Shielding the spleen from X-rays; Removing the spleen provides an indirect

estimate of the amount of antibody it produces. A better experiment could be
done by removing all antibody-forming tissues except the spleen and then following an antibody response.

By utilizing severe X-irradiation to destroy reticulo-

endothelial tissue and by shielding the spleen from this destruction, the above
experiment can be approximatelii. Jacobson and his associates were the first to
show that lead, shielding of the spleen during irradiation protected the immune
response (Jacobson, Robson, and Marks, 1950).

They found that 70-90^ of the

peak hemolysin titer was protected by shielding, although the time of peak titer
was delayed.

The capacity to respond was protected even if the spleen was re-

moved as early as 24 hours after irradiation (Jacobson and Robson, 1952),

These

authors felt that their results proved the role of the spleen in forming antibody.

In later, more extensive experiments, Taliaferro and Taliaferro (1956)

and Sussdorf and Draper (1956) found that shielding the appendix provided even
greater protection of the antibody response than shielding the spleen, this
despite the fact that removal of the spleen showed that it, and not the appendix,
played the major role in hemolysin production following intravenous immunization.
Also with thymidine labeling of cells, they were able to show that cells originating in a protected appendix were responsible for the repopulation of an
irradiated spleen.

These authors therefore concluded that the important factor

in these experiments was the mass of lymphatic tissue shielded rather than the
antibody-forming capacity of the shielded organ.

The shielding experiments only

proved that the protected spleen possesses some factor able to induce the regeneration of antibody-forming capacity.

These results were recently reviewed by

Taliaferro, Taliaferro, and Jaroslaw (1964).
4.)

Cellular changes associated with antibody formation:

It is well known that

following an injection of antigen there occurs, in those organs which are l^egining to produce antibody, a characteristic change in cell types and histological
relationships.

The evidence describing this cellular response will be reviewed

in the following section.

In discussing the lines of evidence which have impli-

cated the spleen in antibody production, it is important to note here that this
cellular response does occur in the spleen and that its occurrence is related
to the amount of antibody produced by the spleen - i.e., after an intraperi<-'t
toneal or intradermal injection, when splenic antibody is known to be less, the
cellular changes in the spleen are fewer,
5.)

Localization of antigen and antibody.in the spleen; Within the last decade

there has been much concern about the organ and cellular localization of antigens
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and antibodies.

Studies in both of these areas have provided indirect evidence

of antibody formation by the spleen.

Implying the organ site of antibody pro-

duction from the cellular localization of antibody assumes, of course, that
neither the cells nor the antibody have been translocated from somewhere else.
On the other hand, the relationship of antigen localization to antibody production is based on the more questionable assumption that where there's fire, there's
eventually going to be smoke.
Whatever its relationship to the site of antibody production, the organ
and cellular localization of antigen has been intensively studied.

Radioactive

labeling of antigen has provided one of the best means of tracing antigen deposition i With this method, both particulate antigens (Benacerraf, Sebestyen, and
Schlossman, 1959) and soluble antigens (Hawkins and Haurowitz, 1961; Roberts and
Haurowitz, 1962) can be found in the spleen after intravenous injection. When
there is less antibody produced by the spleen, as after intradermal injection,
there is less antigen found in the spleen.

Radioactive labeling may denature

the antigen slightly, and some investigators feel that even small modifications
could change the organ and cellular localization.

Such objections may be avoid-

ed by staining tissue sections with fluorescein-conjugated antibody produced
against the antigen.

This technique requires no modification of the antigen ;

prior to its injection,

Kaplan, Coons, and Deane (1950) used this method to

follow the localization of injected pneumococcal polysaccharide in the spleen.
They found most of the antigen in the red pulp of the spleen, although smaller
amounts could be found'in the white pulp,
The Immunogenicity of an injected antigen is perhaps more pertinent to
antibody formation than its localization.

Franzl (1962; 1964) has used the

anamnestic response as an experimental test of the ability of antigen recovered
from different organs still to induce an antibody response.

He found that spleen

homogenates injected intraperitoneally into primed mice provoked antibody synthesis in these recipients even though donor spleens were taken many days after
antigen injection.

In the liver, however, the immunogenicity of the antigen was

destroyed within 12 hours. Haurowitz and his associates have conducted many
studies on the lifetime of antigenic label in the liver.

These results of

Franzl along with other experiments showing that the liver rarely produces any
antibody (Thorbecke and Keuning, 1953; Askonas and White, 1956;'Askonas and
Humphrey, 1958) would seem to question further the: relationship of antigen deposition to antibody formation.

Much of this work on the localization and fate of

antigen has been reviewed by Campbell and Garvey (1963).
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Antibody localization is perhaps better related to antibody formation,
and fluorescent techniques have been used to great advantage in this area.
Both specific antibody (Coons, Leduc, and Connolly, 1955) and "normal gamma
globulin" (Ortega and Mellors, 1957) have been localized in the spleen in
cells around the periphery of follicles, in cells of the red pulp, and in cellular cuffs around small arteries.

Staining in the follicle centers was genem

aXyy diffuse and cell outlines were indistinct there.
erent kinds of antibodies

In more recent work, diff-

and also subunits of antibody globulins have been

localized in the spleen using fluorescent techniques.

Chiappino and Periais (1964)

have demonstrated the presence of both yM and yG globulins in the spleen. Also,
Bernier and Cebra (1964) found both H- and L- chains of 7S y-globulin in individual lymphoid cells of spleens.
6.)

Homologous transfer and in vitro culture of spleen cells: Perhaps the most

convincing proof that the spleen is involved in antibody formation comes from
the ability of spleen cells to produce antibody in homologous recipients or in
in vitro cultures. As early as 1899, Deutsch transferred spleen cells from animals infected with typhoid organisms and found agglutinins in the sera of recipients.

Since he presumably transferred antigen along with the cells, the experi-

ment does not prove that the donor cells were capable of antibody production.
More recently. Chase (1953) transferred spleen cells from guinea pigs having anaphylactic antibodies and high skin sensitivity to simple chemical compounds.
After transfer of cells to normal recipients, he found a rise in both types of
antibody in the recipient sera.

In addition, the amount of antibody produced

in heavily irradiated, isologous recipients has been quantitated and found to
be a direct function of the number of spleen cells transferred (Makinodap,
Kastenbaum, and Peterson, 1962).

The relative capacity of various tissues to

form antibody was studied by Stoner and Bond (1963) who transferred bone marrow,
spleen, lymph node, and thymus cells into irradiated recipients.

The donor ani-

mals received subcutaneous primary and secondary immunizations with tetanus
toxoid. After transfer of equal numbers of each cell type to recipients, tertiary responses were elicited in the recipients by intravenous injection.

The

spleen cells produced neutralizing titers which were 36 times higher than the
titers produced by any of the other three tissues. Although the results convincingly demonstrate the capacity of the spleen to produce antibodies, they
are somewhat surprising in view of the fact that the immunization of donors was
subcutaneous, and this route is known not to involve the spleen maximally.
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Experiments involving similar transfer of cells have been summarized in a review by Cochrane and Dixon (1962).
If animals are immunized and antibody producing tissue is removed after
an appropriate interval, this tissue will continue to produce antibodies in
vitro.

Such an experiment avoids the possiblity that recipient tissue might

also be involved in the formation of antibodies and allows the conditions for
the antibody response to be: more carefully defined and controlled.
experiments have employed splenic tissue.

Many such

Fagraeus (1948)a) showed that ted

pulp removed during a secondary response to S. typhi. produced more antibody
in vitro than the corresponding white pulp.

Many of the factors affecting such

an in vitro response have been detailed by LaVia, Uriu, and Ferguson (1960)
and Vaughan, et al. (1960) using splenic tissue, but they are too nufflfei?ous-to
be reviewed here.

In studying the primary response, Kong and Johnson (1963)

found that in order to get antibody

production they had to wait at least three

days after antigen injection, of donors before transferring spleen fragments to
in vitro cultures.

For transfer to homologous recipients, tissue could be re-

moved one day after antigen. Apparently, cert^to conditions of the induction
period are not satisfied in the cultures but are satisfied in irradiated recipi
ents.

One of thejnmost interesting questions to arise from this work is the

nature of these conditions.

Stavitsky, who did much of the early work proving

the possibility of the antibody response in vitro, has reviewed his own experiments and those <©f many others in this field (Stavitsky, 1961).
Considering the lines of evidence reviewed here, there can be no doubt
that the spleen produces antibody, and that under certain circumstances, particularity after intravenous injection of antigen, the spleen is the major and
sometimes the sole source of antibody.

The cellular changes accompanying anti-

gen uptake and antibody production in the spleen will be reviewed in the next
section.
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C.)

The Cellular Basis of Antibody Production

1.)

The histological response in the spleen
An antigenic stimulus evokes a characteristic differentiation and proli-

feration of cells in the reticular tissues. These cellular changes have been
associated with the production of antibody by fluorescent techniques and other
methods.

I_t is clear that the antibody is formed by a special population of

cells which is almost completely non-existeht before the antigen is administered.
A complete review of the many studies of this response is beyond the scope of
this discussion.

Rather we shall briefly outline the essential changes in

spleen architecture and cell type which occur after an injection of antigen.
The following description is based primarily on the work of Thorbecke and Keuning
(1956) and Langevoort et al. (1963).
On the first day after antigen injection, haemocytoblasts begin to appear
in the periarteriolar lymphocyte sheaths of the white pulp.

There have been

various suggestions that these cells are derived from the germinal center reticulum cells (Fagraeus, 1948 b; Marshall and White, 1950), from the lymphocytes
surrounding these arteries (Langevoort et al., 1963), or from small (circulating?)
lymphocytes (Gowans, Gesner, and McGregor, 1961; Porter and Cooper, 1962).

The

haemocytoblasts are large rounded cells with large, central pale nuclei. They
have prominent nucleoli and a narrow zone of pyronindphilic cytoplasm.

During

the second and third post-antigen days, these cells increase in number and apparently migrate to the periphery of the white pulp.

The haemocytoblasts are coll-

ected there around the penicilli arterioles so that they are characteristically
seen in groups of "aggregates." Sometime these aggregates are within the red
pulp, but usually they are located on the border of the red and white pulp.
By the fourth and fifth days, germinal centers (secondary nodules) begin
to appear in the white pulp.

These often contain mitotic figures, blast-like

cells, and medium lymphocytes in increased numbers. At the same time, the
haemocytoblasts begin to differentiate into immature plasma cells. They become
smaller, more basophilic, with darker muclei caused by some condensation of the
chromatin.

The nuclei begin to be more eccentrically located.

The nucleoli are

still clearly visible. Within another two days, these cells become typical mature plasma cells: they have eccentric nuclei with cartwheel patterns of densely
clumped chromatin, no visible nucleoli, and strongly pyroninophilic cytoplasm
with a characteristic juxtanuclear clear zone. Mature plasma cells are the
smallest of the three types. With most antigens, the plasma cells are seen in
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large numbers bordering the white pulp lymphoid tissue for only a week or so;
by the end of the second week after antigen administration, the plasma cells
disappear rather rapidly and can be found only occasionally in animals given
no further stimuli.

Throughout the time that the plasma cells become predom-

inant at the borders of the red pulp, the germinal centers show increasing signs
of cell disintegration and phagocytosis (tingible-body macrophages), and they
exhibit a typical "starry sky" a{)pearance.
The white and red pulp of the spleen can be separated with the aid of a
dissecting microscope and cultured apart in vitro.

Fagraeus (1948 a), Thorbecke

and Keuning (1953), and Langevoort et al. (1963) have studied the relative antibody production of these two parts of the spleen in this manner and have concluded that most of the antibody is formed In. therexl pulp rather than in the germinal centers of the white pulp.

Presumably, the plasma cell aggregates along

the border between the two are removed with the red pulp in this technique.
These conclusions have been substantially supported by studies of antibody localization with fluorescence.

What then is the role of the secondary nodules?

It seems curious that the secondary nodules reach their peak of development
after the production of antibodies has subsided, and that these sites of greatest morphological change and cellular proliferation are topographically removed
from those parts of the spleen which produce antibody.

There have been recent

suggestions that these nodules do not play a role in the primary response, but
that they form those cells which rapidly respond to a booster injection - that
they are the sites of the immunological memory.

The exact function of these

nodules, however, is still somewhat controversial (Thorbecke et al., 1962; White,
1963).
As a final note to the discussion of histology:

in recent years, many

experiments have stressed the possible importance of intimate cell associations
in the immune response, particularly the association of macrophages with cells
of the lymphocytic and plasma cell families.

The lack of phagocytic activity

in cells producing antibody has always been problematical to theories of antibody formation.

Is antigen necessary in these cells, and if so, how does it get

in? What happens to the antigen taken up by phagocytic cells? Recent studies
of the primary response in vitro (Fishman, 1961; Fishman, Hammerstrom, and Bond,
1963) have suggested that the macrophage may be involved in the transfer of
some activating principle to immunologically competent cells,

These experiments

have stimulated other investigators to look for histological evidence of cell
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interactions which may play a role in the antibody response (White, 1963; Foy
and Kondi, 1964; Schoenberg et al., 1964 a; Miller and Nossal, 1964).

A good

evaluation of the role of such cell interactions, however, will have to wait
for more convincing in vitro experiments.
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2.)

Cell types producing yM and yG antibodies
Immunology as a subject of inquiry has often been plagued with redundant

and imprecise terminology,

Within this subject, a major area of debate has been

the cellular basis of antibody production.

Since the work of Fagraeus (1948 b),

antibody production has been associated with the plasma cell and its immature form,
the transitional cell, of Fagraeus (haemocytoblast). Experiments detailing the
role of these cells almost always involved hyperimmunized animals so as to insure
high levels of yG antibodies. After the discovery of yM production in such disease
as Waldenstrom's maqroglobulinemia and the importance of yM in the primary antibody response, questions arose about the cellular source of this antibody - are
yM and yG produced by different cells?

If so, does a change in cell morphology

accompany the transition from yM to yG? Despite much interest and experimental
work, this one cell - two cell controversy continues.

It would perhaps be easiest

to review the evidence for each side of this debate in a tabular form, much as we
presented the experiments showing yM-yG transition, but this is not possible because the confusion in terminology is such that the work of a single author has
at times been claimed by both sides^ and a definitive statement of opinion is rare
indeed.

We shall be forced to make as good an assessment as possible by reviewing

the individual papers.
Most studies on the cellular basis of yM production have taken advantage of
situations in which yM is the dominant antibody type. Macroglobulinemia and rheumatoid arthritis have both been well studied.

The technique most commonly used

has been fluorescent staining of cells for the presence of antibody.

Yet despite

the use of similar materials and methods, the results and conclusions have seemed
contradictory.

Thus, Curtain and O'Dea (1959) and Curtain (1961) studied cellular

localization of antibody in macroglobulinemia and found specific fluorescence in
plasmablasts but not mature plasma cells; and Mellors et al. (1959), Mellors,
Nowoslawski, and Korngold (196X), and McCormlck (1963) all studied the cellular
origin of rheumatoid factor and found that both yM and yG globulins were located
in both immature and mature types of plasma cells, Mature lymphocytes were not
stained, All these authors felt that the same cell therefore produced both yM and
yG.

On the other hand, Braunstelner, Fellinger, and Pakesch (1957) found organ-

ized ergastoplasm in lymphoid cells of macroglobulinemia suggesting protein synthesis of a large order, Waldenstri^m (1958) found that "lymphocyte reticulum cells"
were preponderant in spleen, nodes, and bone marrow in macroglobulinemia, and
Dutcher and Fahey (1959; 1960) described specific fluorescent staining of "lymphoid
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plasma cells" in similar patients.

In a study which included both fluorescent

localization and production of macroglobulins in vitro, Zucker-Franklin, Franklin,
and Cooper (1962) found that patients with macroglobulinemia had no increase in
typical plasma cells.

Cells staining for yM antibody were either large or medium

lymphocytes of "lymphoid reticulum cells." Thus, one might conclude that there are
two different cells involved.
Such studies have not been confined to disease situations; the primary antibody response has also been a source of conflict.

For instance, Asofsky and

Thorbecke (1962) studied the production of yM and yG in vitro and found that the
"ability of tissues to form both 7S and 19S y-globulin was closely correlated with
the appearance of immature plasma cells." Langevoort et al. (1963) concluded that
"immature and mature plasma cells" in the red pulp were responsible for yM production in the primary response.

Yet Schoenberg, Rupp, and Moore (1964 b) report

the production of yM antibodies by "a large mononuclear cell with cytoplasmic basophilia."

They feel that this cell

is unrelated in origin to the plasma cell which

produces yG and that there is no morphological transition from one to the other.
What then is the source of confusion in this work and what can be concluded
from the experiments reviewed here?

For one thing, a major source of difficulty

is the similarity of the cells central to the debate - the large lymphocyte and
immature plasma cell are very similar in appearance.

Oftentimes, no light micro-

scopy accompanies the fluorescent observations and the determination of cell type
is done without reference to nucleoli, chromatin density and arrangement, or cytoplasmic basophilia.

When rather poor, low power pictures are presented, the

reader is at the mercy of the investigator's skill,at differentiating the two
cell types.

Secondly, some of these conclusions are based merely on the "pre-

ponderance" of one cell type in a disease state or the presence or absence of a
cell type at times of yM production.
by no means conclusive.

Even studies employing immunofluorescence are

The demonstrated immunologic cross-reactivity of yM and

yG globulins (Thorbecke and Franklin, 1961) makes the application of immunofluorescent techniques at best problematical.

Careful

absorption controls and elimina-

tion of background staining have not always been done.
Another source of difficulity has been the multiplicity of names used to
describe the same cell type and the surprising number of cell types often included
under the same name. ^ For instance, do "lymphocytoid plasma cells" and "plasmacytoid lymphocytes" belong to the same or different families?

Or consider a vstudy

of y and pLA myelomas by Burtin and Buffe (1963) in which they stated that "fluorescent; cells were always plasma cells"; yet, the size of the cells described was
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variable, the nuclei showed a broad range of size and location, some cells had
budding or irregular nuclei, and even bi- or multinucleated cells were seen. Also,
Zucker-Franklin et al. (1962) show a "large lymphoblast" with a distinctly eccentric nucleus, a property which many investigators find ipso facto definitive for a
plasma cell.
The controversy in this field has largely been directed to the question of
whether two different cells produce the two globulins.

Perhaps much of the con-

fusion stems from what we mean by "two different cells." For some persons, production by two different cells implies different pell families, different cell
morphology, and no possible transitions between the two. For others, differences
in morphology alone constitute different cells. As an example, if a haemocytoblast produces yM antibody and then matures to a plasma cell which produces yG, is
this the produation of both types of antibody by one cell or two different cells?
Though the distinction may seem insignificant, the failure to make^ it has caused
much confusion throughout the literature.

Thus, in a study of dysgammaglobulinemia,

Cruchard et al. (1962) found yM in transitional cells of Fagraeus.

Because of a

failure to distinguish basic definitions, this one paper has recently been cited
both in support of a one cell theory (Nossal et al., 1964) and also in support of
"two major cell lines" (Robbins and Smith, 1964).

To show that this is not an

isolated example: Curtain and O'Dea (1959) are cited as support for the role of
the plasma cell by both Nossal et al. (1964) and Franklin (1964), while the same
paper is cited by Schoenberg et al. (1964 b) as supporting the production of yM
by the lymphocyte.

Perhaps the criterion for differentiating between one cell pro-

duction and the production by two cells should not be a morphological difference
but rather the ability of the yM produceing cell to change over or transform into
a cell producing yG antibody.

Histological studies are largely inconclusive on

this point.
Therefore, it may be that different cell types produce yM and yG but that
one cell line or family is involved.

Perhaps the transition from a large blast-like

cell to a mature plasma cell is accompanied by a transition from yM to yG production. Macroglobulinemias or myelomas might then represent a maturation arrest at
one or another stage in this globulin-producing cell line.

The globulin type may

not always be exactly correlated with the cell morphology.

Thus, while most macro-

globulinemias exhibit a preponderant lymphocytic reticulum cell, there have been
reports of macroglobulinemias where plasma, cells were dominant in the bone marrow
(Engle, 1959).
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In this regard, three recent papers are most interesting (Solomon,
Fahey, and Malmgre, 1963; Mellors and Korngold, 1963; Chiappino and Pernis, 1964).
These papers contain observations on the cellular localization of yM and yG by the
use of immunofluorescence.

They include studies of large numbers of patients with

multiple myeloma, macroglobulinemia, rheumatoid arthritis, and also patients with
various unrelated disorders. All three studies find no correlation between cell
type and type of antibody globulin,

Both yM and yG were observed at different

times in large, blast-like, immature forms, in germinal center reticular cells,
in cells resembling intermediate stages between lymphocytes and plasma cells,
and in immature and mature plasma cells. Thus, in large samplings in the absence
of specific antigen stimulation there may be little correlation of either yM or
yG with any one cell type.
If yM and yG can be associated with a variety of cell types, what of their
occurence together in a single cell? Despite the failure of some authors to find
cells that produce two antibodies (Burtin and Buffe, 1963; Solomon et al., 1963;
Chiappino and Pernis, 1964), there have been other reports with double fluorescence
of both yM and yG in the same plasma cell (Mellors et al., 1959; Mellors et al.,
1961; Mellors and Korngold, 1963; McCormlck, 1963).

The low incidence of cells

producing both types agrees with previous work on single cell producing antibodies
of two specificities (Attardi et al., 1959; Makela and Nossal, 1961).
Perhaps the most direct and convincing evidence that one cell line can be
involved in both yM and yG production comes from recent single cell studies of
the primary response (Nossal et al,, 1964).

Of 123 cells containing antibody

examined at various times during a primary response, 21% were blast cells, 31%
were immature plasma cells, and 47% were mature plasma cells. No morphological
differences were observed between yM and yG containing cells. At a time when
yG was first beginning to replace yM in the serum, 7 cells were found which
contained both types of antibody.

Though there is no proof that the same cell

produced first yM and then goes on to produce yG, such a theory would seem to
have the most support from evidence presently available.
The work reviewed thus far has dealt exclusively with various kinds of
morphological evidence.

Before ending this section, we might mention some other

authors who favor the involvement of two cell types on the basis of kinetic or
functional studies. Reasoning from such facts as a) the concurrent synthesis of
yM and yG in certain cases, b) the differences in kinetics of formation of the
two antibodies, c) differences in antigen dosage threshold, d) the presence of
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long-term memory of only one kind, and e) the different susceptibility of each
to depression by X-ray, these investigators have concluded that two major cell
lines are necessarily involved (Bauer, Mathies, and Stavitsky, 1963; Svehag and
Mandel, 1964 b; Robbins and Smith, 1964).

Such logic is on rather tenuous

ground at present, since there seems to be no reason to exclude major physiological
differences between two members of the same cell line.
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II.

MATERIALS AND METHODS
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^•^ ANIMALS: mice used in all experiments were of the Nelson-Collins-Swiss
strain developed at the Rockefeller Institute.

The mice are specific pathogen

free and are randomly bred in a closed population.

Mature male mice weighing

23-28 grams (5-7 weeks old) were used throughout. Animals were fed ad libitum
a diet of pathogen free commercial mouse pellets (Dietrich and Gambrill, Frederick,
Maryland) and tap water.

None of these mice were found to have detectable antibody

titers against any of the antigens used in these studies.
B.) ANTIGEN;

the flagellated salmonellae used in these studies were obtained

from Dr. P.R. Edwards of the Communicable Disease Center, Atlanta, Georgia.
S. adelaide (35:f,g) was used for immunization and subsequent titration.

Control

titrations were done using S. umhlatazana (35:a) and S. derby (1,4,12:f,g).
Overnight cultures of S. adelaide were grown in penassay broth (Difco
Laboratories, Detroit) on a reciprocal shaker at 37*^ C.

Formalin was added to

a concentration of 0.25% and the flasks were further shaken at 37 C for 15
minutes and allowed to stand at 4 C overnight.

The bacteria were washed three

times in saline, collected by centrifugation at 9,000 X G, and resuspended in
sterile, physiological saline.

Optical density was measured at 650 mi-i in the

small tubes (0.9 cm. I.D.) of the Coleman Junior Spectrophotometer. The O.D.
g
was adjusted to 0.4 which corresponded to a viable count of 5 x 10 organisms
per ml, and a dry weight of 0.95 mg./ml. This antigen was stored at 4 C without
preservatives.

The stock was often checked for contamination and loss of immuno-

genicity, and it was never kept longer than three months.

Intact bacteria were

used for immunization in all experiments.
C.)

IMMUNIZATION:

maximal primary antibody responses were elicited by injection

of 0.2 ml. of stock antigen into the tail vein. When the secondary antibody response
was studied, stock antigen was diluted 1 to 4 in saline, and mice were injected
with 0.2 ml. of this dilution 35-40 days after the primary injection.
D.)

COLLECTION OF SERA;

blood was collected from mice under ether anesthesia

by direct heart puncture and allowed to clot at room temperature.

The clot was

rimmed and allowed to retract overnight at 4 C, then centrifuged, and the serum
o
was removed and stored at 4 C until assay.
E.)

HOMOGENIZATION OF SPLEENS;

spleens were removed under ether anesthesia,

trimmed of connective tissue, and homogenized in 1 ml. of cold saline with a
motor driven teflon pestle (Tri-R Instruments Jamaica, N.Y,, 2 ml. capacity).
Twenty passes of the pestle over a period of 2 minutes were performed while the
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tube was kept in an ice bath.

The resulting homogenate showed very few unbroken

cells when examined under phase contrast.

The homogenate was centrifuged at 4°C

using 5 ml. lusteroid tubes (Lourdes, 9RA rotor).

After centrifugation for 15

minutes at 11,000 rpm (15,000XG), the supernatants were collected and were stored
at 4 C for titration the same day.
F.) ANTIBODY TITRATIONS:

The pellets were discarded.

anti-flagellar antibody was detected by a modification

of the technique originally described by Nossal (1958) utilizing the specific
immobilization of motile bacteria.

Bacteria were maintained at maximal motility

by daily passage through a semi-solid nutrient medium (0.47o agar, 8% gelatin in
penassay broth) in a petri dish (Lederberg, 1956).

Organisms from the leading

edge of the culture were taken up with a 4mm. loop and innoculated into 5 ml.
o
of fresh penassay broth. The culture was incubated for 2-3 hours at 37 C before
use in the titrations. Liquid cultures grown in this way routinely showed 95-100%
motile organisms.

If heavier growth was allowed, the percentage of motile bacteria

decreased.
Sera and spleen homogenate supernatants were diluted in saline in 2 ml.
cups of disposable plastic trays.

Serial two-fold dilutions were done with an

automatic pipet (Arthur H. Thomas Co., Philadelphia, No. 8212-E) of 0,2 ml.
capacity.

The final volume of all dilutions was 0.1 ml. An equal volume of

a 2-3 hour culture in penassy broth was mixed with each dilution and allowed to
stand for 20 minutes before counting.

All operations were performed at room

temperature.
Counting chambers were similar to those of de Fonbrune (1949).

A thin

layer of mineral oil (Nujol, Plough Inc., N.Y.) was spread over the surface of
a clean glass microscope coverslip (No. 1, 22x50mm.).

Kimax capillary tubing

(0,7 - 1.0 mm.) was drawn into micropipets and a separate pipet was used to deposit
a droplet of each dilution beneath the layer of oil.

On a 3"xl" glass microscope

slide, a rectangular area was enclosed with liquid wax on three sides. The
coverslip was inverted on the hardened wax and the space beneath it was filled
with mineral oil. This method gave chambers of varying depths depending on
the thickness of the wax, however, this did not affect the results of the experiments.

The resolution in phase contrast was better if the microdroplets contacted

both the top and the bottom of the chamber,
Microdroplets were observed with high dry phase optics (Zeiss Ultraphot II;
400-640 magnification). Bacteria showing any movement other than Brownlan motion
were judged motile.

Fifty to one hundred bacteria were counted.

Care was taken
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always to count throughout the height of the drop, as there were sometimes more
immotile bacteria towards the bottom.

The specificity of the immobilization of

bacteria by antibody, a representative titration, and the establishment of endpoints will all be discussed in the section on "Results."
G.)

ZONE ELCTROPHORESIS OF SERA:

a modification of previous techniques was used

(Kunkel and Slater, 1952; MHller-Eberhard, 1960).

One ml. of serum was placed in

a trough 4" from the end of a block of polyvinyl chloride (Pevikon, Mercer Chemical Co., New York distributor) 18x7x0.6 inches. Electrophoresis was carried out
in 0.1 I-l barbital buffer, pH 8,6, for 18 hours at 250 volts, 50 ma., and a temperao
ture of 4 C, One-half inch strips were cut from the block, and the protein was
eluted with 3 ml. saline under negative pressure through a coarse glass filter.
The protein content of the eluates was determined by the method of Lowry et al.
(1951).
H.)

ULTRACENTRIFUGATION OF SERA AND HOMOGENATES:

density gradient centrifugation

was carried out according to methods described by Edelman, Kunkel, and Franklin
(1958) and Kunkel (1960). A Spinco model L centrifuge at a constant temperature
o
of 4 C was used with the SW-39 swinging bucket rotor. A continuous gradient
ranging from 10-40% sucrose from the top to the bottom of the tube was made by
dropwise addition of 40% sucrose to 10% sucrose in a mixing chamber.

The gradient

was cooled to 4 C, and 0.2 ml. serum or homogenate supernatant was carefully
layered over the sucrose.

The lower portion of the protein solution was stirred

slightly into the sucrose in order to minimize droplet formation, and the ultracentrif ugation was begun immediately.
at 35,000 rpm.

All gradients were centrifuged for 18 hours

Sera were not concentrated before application to gradients; spleen

homogenate supernatants were concentrated two-fold by means of ultrafiltration
through collodion bags under negative pressure (Carl Schleicher and Schuell Co.,
Keene, N.H.; porosity less than 5 millimicrons).
Fractions of the centrifuged density gradient were obtained by piercing
the bottom of the plastic centrifuge tube with a standard needle and collecting
a given number of drops in each tube of a fraction collector.
was controlled by negative pressure above the solution.

The speed of efflux

The fractions were titered

for antibody without prior dialysis.
The sedimentation coefficients of the antibodies were not precisely
determined in the analytical ultracentrifuge.

The activities sedimented, however,

in the same gradient fractions as 19S and 7S antibodies in the rabbit and in man
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(Kunkel, Rockey, and Tomasi, 1961).

For convenience, therefore, antibodies

sedimenting in the central portion of the gradient will be called yG (for 7S
y-globulin) and antibodies sedimenting to the bottom of the gradient will be
called yM (for 19S y-globulin or y-macroglobulin). This is in accord with
the changes in Nomenclature for Human Immunoglobulins

(Bull. Wld. Hlth. Org.,

301447, 1964).
I.)

MERCAPTOETHANOL TREATMENT OF SERA:

2-mercaptoethanol (2-ME) was added to

serum to a final concentration of O.IM (1/128 by volume), mixed, and allowed to
stand at room temperature for two hours in a tightly sealed tube.

Titrations

were carried out in the presence of 2-ME without any decrease in control
motility.
J.)

SPLENECTOMIES;

spleens were removed from normal mice under light ether

anesthesia. A single silk ligature was placed around the pedicle to control
bleeding.

Care was taken to remove any accessory splenic tissue. Wounds were

closed with 11 mm. Michel clips and collodion.
post-operative rest before antigen injection.

The mice were allowed 11 days of
At the time they were bled for

antibody determination, all mice were re-examined for regrowth of splenic tissue.
Laparotomy was performed on all control animals.
K.)

LOCALIZATION OF ANTIGEN;

uniformly labelled D-glucose-C-14 was obtained as

a lyophilized syrup (Volk Radiochemical, Skokie, Illinois; No. CC-24, 4.66
mc/mM).

The following basic medium was used for growth of bacteria;

0.2% am-

monium sulfate, 1.4% dipotassium phosphate, 0.6% monopotassium phosphate, 0.1%
sodium citrate, 0.02% magnesium sulfate • 7H 0, 0.1% yeast extract dialysate,
and 0.01% casamino acids (Cohn, 1963), The final medium contained lOjic of
14
C
- glucose per ml. A small inoculum of S^. adelaide was added to 10 ml. of
o
this medium in a tightly stoppered 50 ml. flask and incubated at 37 C on a
reciprocal shaker for 12 hours. Unlabelled glucose was then added, and the
culture was killed with formalin after one additional hour. The bacteria were
washed three times with saline, collected by centrifugation at 9,000XG, and
resuspended to an 0,D, of 0.40 as described above for unlabelled antigen.

Normal

mice were injected with 0.20 ml. (162,000 cpm) of this stock antigen to elicit
a primary response.

To study the

localization of the antigen in the secondary
14
response, 0.20 ml. of a 1/4 dilution of C
stock antigen was injected 37 days
after the primary injection of unlabelled antigen.
Heparinized cardiac blood was obtained at varying times after the injection
of antigen.

The spleen, lungs, and liver were digested in appropriate volumes of
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IN NaOH.

The digestion proceeded at 37 C for 15 hours.

Known volumes of each of the four fractions were placed on metal planchets
and dried slowly under an infra-red lamp, A small drop of Roccal (Winthrop
Laboratories, New York) was added to each planchet to give even spreading. Radioactivity was then assayed in a micromil end-window gas flow counter (Nuclear-Chicago)
At least 2,000 counts above background were recorded for each sample.

Self-absorp-

tion curves were prepared for each fraction, and samples were corrected and expressed
to infinite thinness,
L.)

INHIBITION OF THE PRIMARY IMMUNE RESPONSE-: methotrexate sodium (4-amino-N'''°-

methyl pteroylglutamic acid sodium) was obtained from Lederle Laboratories, Pearl
River, and was dissolved in distilled water; colchicine, USP, was obtained from
Amend Drug and Chemical Co., New York, and was dissolved in physiological saline.
Both drugs were administered intraperitoneally in volumes of 0.5 ml.

Dosage and

frequency is indicated in each experiment,
M.)

TRANSFER OF PRIMED SPLEEN CELLS;

the suspending medium in all parts of the

transfer experiments was Medium No, 199 with sodium bicarbonate (Microbiological
Associates, Bethesda) and 10% fresh normal mouse serum.

Donor mice were anesthetized

with ether and their spleens were removed sterilely and placed in a small petri
dish.

The spleens were minced using a sharp, single-edge razor blade.

The resulting

pulp was then wrapped in a square of hem from a woman's nylon stocking which had
previously been boiled free of dye and autoclaved.

This stocking bag was immersed

in 1 ml. of transfer medium per spleen and very gently squeezed to free the cells
from within.

Very little manipulation was necessary to free most cells. Any

attempt to free all of the cells in the bag required rougher treatment and resulted
in a greater percentage of dead cells.

The connective tissue was left in the

stocking bag and was discarded.
The cells were centrifuged at 800 rpm for 6 minutes and resuspended to a
8
concentration of 2 x 10 cells per ml. All cell counts were done in a standard
hemocytometer using Turk's solution as a diluent. A differential count of these
wet preparations showed an average of 13% large mononuclear cells, 85% small
Q

and medium lymphocytes, and 2% other types.

One-half ml. (1 x 10

injected into the recipient's tail vein using a 26 gauge needle.

cells) was
The number of

cells injected was approximately 30-50% of the cells which could easily be freed
from one donor spleen. All media were kept at room temperature during an experiment, and the transfers were routinely completed in less than two hours.
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The uptake of trypan blue was used to determine the percentage of cells
living at the end of an experiment.

Equal volumes of 1% trypan blue in saline,

normal mouse serum, and cell suspension were mixed and incubated under a sealed
o
coverslip for 15 minutes at 37 C, Only cells whose nuclei did not stain blue
were considered alive. The viability of cells as determined by this method, was
routinely 85-90% at the end of an experiment,
N.)

IRRADIATION OF RECIPIENT MICE;

the facilities of the radio-therapy division

of New York Hospital were used for all X-irradiation of recipient mice.

Mice were

separated from each other by dividers in a cardboard box, and six mice at a time
were given 650r surface dose using a GE Maxitron according to the following specifications:
250 KV
filters;

30 ma
Jmm, Cu, 1mm,Al

100 r/min. (air)
backscatter;

TSA:

50 cm.

HVL;

1,5 mm. Cu

135 r/min. (skin)
2
area: 300 cm

1.35

The mice were irradiated 24 hours prior to receiving cells. At this dosage,
better than 90% of the mice survived more than 40 days whether or not they
received cells.
0,)

HISTOLOGICAL STUDIES;

all sections were prepared from whole spleens fixed

in formalin;distilled water (10:90).

The spleens were paraffin embedded and

stained with methyl green - pyronin according to the method of Kurnick (1955)
with the exception that ethyl alcohol was substituted for butyl alcohol.
All photographs were taken with a Zeiss Ultraphot II microscope using
4" X 5" Anscochrome 3200 film plates.
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III.

RESULTS
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A.)

GENERAL CONSIDERATIONS;

the method of antibody titration used in the

following experiments was adapted from earlier studies on the production of
antibodies by single cells (Nossal, 1958).

Nossal had taken the immobilization

of more than 90% of test bacteria as a positive indication of antibody production.
In the present work, it was felt that a more precise and possibly more sensitive
determination of endpoint was needed to achieve accurate kinetic studies. A
technique was developed for growing cultures which were routinely 99+% motile
and endpoints of titrations were determined by counting the percentage of test
bacteria immobilized at each dilution. A typical titration curve is shown in
Fig. 1.

There were usually four to five doubling dilutions between complete

immobilization and control values. The range of values at the same dilution
was less than 15%. The spontaneous immobilization of controls never exceeded
the indicated range, in any of the following studies.

The endpoint of a titration

was chosen as the highest dilution containing more than 25% immotile test
bacteria.

On repeated titration of the same serum, the standard deviation of

endpoints was less than one doubling dilution.
The specificity of the immobilization was tested using salmonellae of known
serological types. Mice were immunized with S. adelaide of flagellar type;
(H antigen).

f,g

The resulting antisera w^re titered with the original immunogen,

with a strain having a common H antigen, and with a strain having a common 0
antigen (Table II). Only those test bacteria having an H antigen in common
with the immunogen showed significant immobilization.

Other controls in which

mice were immunized with S. derby or S. umhlatazana gave similar results.
B.)

THE ORGAN LOCALIZATION OF INJECTED ANTIGEN:

the clearance and organ

localization of injected particulate antigens have been studied by many investigators

(Bull, 1915;.'5ullivan, Nekerman, and Cannon, 1934; Kerby, Holland, and

Martin, 1950; Benacerraf, Sebestyen, and Schlossman, 1959).

Because antigen

localization is known to Vary dramatically with the type of organism, the animal
used, and the natural opsonins present, it was decided to restudy the distribution
of injected antigen under the present circumstances.

Carbon-14 label was used

because it was more stable than the P-32 used in previous work (Benacerraf et
al., 1959).
Fig, 2 presents the summation of data collected during the first week
of the primary response.

During the first six hours after immunization, counts

in the blood decreased exponentially to less than 2% of the initial injection.
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Fig. 1

The immobilization of motile test bacteria by a specific antiserum.

Reciprocal Titer
Test Bacteria

5 day

15 day

S. adelaide (35 ; f,g) 256 512

S. derby (1,4,12 : f,g) 256 512

3. umhlatazana (35 : a) 0 4

Table II

The specificity of immobilization by an antiserum produced
against S. adelaide (35 : f,g).

Initial injection 160,000 cpm
100,000 rr

Primary response

10,000 J
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o
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Days after injection
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Fig. 2
The localization of C
week after primary injection.

labeled S. adelaide during the first
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The counts in the three organs studied rose rapidly during this time, but they
sharply decreased in the lung and the spleen during the next 18 hours. After
the first 24 hours of the response, the levels of radioactivity declined
at a steady rate in the three organs studied and in the blood.

These rates

remained the same when followed for as long as 15 more days.
Fig. 3 and Fig. 4 show the recovery of injected antigen in each of the
organs and the radioactivity per wet weight of tissue.

The spleen had a higher

specific activity than either lung or liver and showed relatively greater phagocytic capacity than was expected from the results of studies in other animals,
This might be caused by the relatively poor phagocytic effiqiency of the mouse
liver which has been described by Dobson and Jones (1951).

They attributed their

results to the greater speed of blood passage through the liver in the mouse as
compared to other mammals.

In the present studies, the spleen captured relatively

larger amounts of antigen than the liver when there was no circulating antibody
detectable.

In the presence of specific opsonins, however, the liver removed

almost all of the injected antigen and also had a higher specific activity than
the spleen.

These latter results will be presented in Appendix I.

This dependence

of organ localization on level of circulating antibody is in agreement with the
results of Benacerraf et al. (1959).
C.)

THE PRIMARY IMMUNE RESPONSE:

In view of the relatively large uptake of

S. adelaide by the spleen after a primary injection, it was of interest to assess
the role of the spleen in

antibody production as well as antigen localization.

The primary response was therefore studied in both spleen homogenates and in
sera of mice.
A preliminary study was made of the change in weight of the spleen after
antigen injection.

It is well known that during the inductive phase of antibody

formation, there are cellular changes in lymphoid tissue which are accompanied
by enlargement of the tissue and an increase in its weight (Bjorneboe and Gormsen,
1943).

In the spleen, this is caused by hyperplasia of the white pulp and not

by edema or erythrocyte infiltration (Norton, Wolfe, and Crow, 1950,)

This weight

increase has been correlated with increases in the organ content of DNA and RNA
(Ehrich, Drabkin, and Forman, 1949; Harris and Harris, 1949; Makinodan, • Ruth,
and Wolfe, 1954) and with increased levels of protein synthesis (Wust and Novelli,
1962).

In the present study (Fig. 5), spleen weights increased sharply from the

time of antigen injection to peak at nearly three times control values on day 4.

100

Primary response

80

c
cu
a>
c
o
•o
•4—

o

0)

Q_

Spleen
.-^Blood
1*-Lung

1

2

3

4

Days after injection

Fig. 3

The relative percentage of injected antigen recovered in each

of the organs and in the blood.
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The change in the wet weight of the spleen during the primary
response.
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This increase occurred despite the fact that during the first 24 hours of the
response the mice underwent a characteristic endotoxin reaction:

a loss in total

body weight, drop in peripheral leucocyte count, decrease in body temperature,
and diarrhea.

The spleen weights then declined until day 9 when a smaller second

increase in weight was seen.

The second peak rapidly declined to control values "^

by day 12. The bimodal nature of the spleen weight curve with this antigen was
confirmed in a number of experiments.

Similar bimodal curves were not noted in

any of the studies cited above.
Antibody titers found in the serum and in spleen homogenate supernatants
are shown in Fig. 6.

Specific antiflagellar antibodies first appeared in the

serum on day 4 and could be found in the spleen one day earlier.

The serum titer

increased exponentially until day 7 and then slowly declined during the remainder
of the first month.

The antibody content of the spleen was represented by a

bimodal curve with a small peak on day 5 and a second, larger peak on day 10.
Although the spleens were not perfused to remove blood before homogenization,
the change in splenic titer was not correlated with any change in the serum
titer. Also, controls done with equivalent weights of non-perfused liver tissue
did not show detectable antibody titers.

Thus, it seemed a fair assumption

that

homogenate titers were a measure of the antibody produced by the spleen itself.
It was of interest that the curves representing the change in weight of the
spleen and its antibody content were each bimodal and corresponded to each other
in time. Bjorneboe and Gormsen (1943) associated sharp increases in spleen weight
during a primary response in rabbits with increases in the percent of antibody
protein in the serum.

In the present study, there was no relationship between

the weight of a spleen and its antibody content (Fig. 7). It is not clear whether
the fact that the two curves are both bimodal is significant in some other way.
The previous experiments of Stelos and Talmage (1957) and Bauer and Stavitsky (1961) suggested that the bimodal curve of antibody content of the spleen,
as observed in these experiments, might be caused by the asynchronous production
of two different kinds of antibody globulin.

Attempts were made, therefore, to

characterize the antibody activity both early and late in the primary response.
In the results presented below, spleen homogenate supernatants were generally
harder to work with because of the extremely low titers, and experiments with
sera will be emphasized.
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D.)

PHYSICOCHEMICAL PROPERTIES OF PRIMARY RESPONSE ANTIBODIES:

1.)

ELECTROPHORETIC SEPARATION:

both 5-day and 10-day antisera were examined

by zone electrophoresis and antibody activities were determined in consecutive
segments (Fig. 8). Some increase in antibody activity migrating in the y-2
region could be found at 10 days with respect to day 15. Although the separation
of activities by this method was not optimal, these results were consistent with
earlier suggestions cited above that the primary response consisted of the initial synthesis of y-1 globulins followed by the later synthesis of antibodies
with y-2 mobility.

With repeated attempts, it was difficult to sharpen the

distinction between days 5 and 10 using this technique, and the electrophoretic
characterization was not pursued.
2.)

ULTRACENTRIFUGATION:

a better distinction of the early and late antisera

was achieved by ultracentrifugation in sucrose density gradients. Antibody
titers were determined in consecutive fractions of each gradient, and the
results at different times during the primary response are shown in Fig. 9.
At day 5, all the antibody activity was associated with the fastest sedimenting
fractions, indicating that these antibodies were macroglobulins.
slowly sedimenting antibody activity began to appear.

On day 7, more

By 10 days, this lighter

antibody accounted for approximately half of the antibody content of the serum.
The macroglobulin activity continued to decrease, until by 20 days after antigen
injection, the transition from heavy to light antibody activity had been completed
in the serum,

o

Centrifugation of spleen homogenate supernatants in density gradients
showed that the first peak detected in the spleen consisted entirely of macroglobulin activity.
lighter antibody,

The second spleen peak, at 10 days, was composed solely of
Both antibodies found in the spleen sedimented in exactly

the same gradient positions shown in serum studies.
3.)

MERCAPTOETHANOL TREATMENT;

the depolymerization and loss of activity of

macroglobulin antibodies in the presence of sulfhdryl reagents has been reviewed
by Franklin (1964).

This specific inactivation has become a convenient means

for differentiating macroglobulin from ligher weight (7S) antibody activity.
When the density gradient fractions isolated above were incubated for two hours
at room temperature in the presence of 0.1 M 2-ME, the fast sedimenting fs^actions
lost all antibody activity.

More'slowly sedimenting antibody was not affected.

Cathode
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_ Normal serum
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0.21-

Fraction number

Fig. 8

The electrophoretic separation of immune sera.

Sucrose density gradients
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5
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-Bottom of tube

Fig. 9

The ultracentrifugation of primary response antisera in sucrose

density gradients.
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The correlation of sensitivity to sulfhydryl inactivation with ultracentrifugal and electrophoretic behavior was consistent with the idea that the two
antibodies described here were identical with yM and yG antibodies found in other
studies.

This terminology will be employed below.

Also, throughout the following

experiments, only the sensitiviby to 2-ME was used to differentiate yM from yG
activity.
In almost every system studied thus far, yM antibodies lose all antibody
activity upon reduction with 2-ME while yG antibodies are not affecte^.

There

are, however, at least two unconfirmed reports of residual yM activity after
2-ME treatment (Smith, 1960; Chan and Deutsch, 1961).

Also, subunits of 2-ME

treated macroglobulins may retain some binding capacity (Onoue et al., 1964;
Schrohenloher, Kunkel, and Tomasi, 1964; Hill and Cebra, 1965).
cases, 2-ME may inactivate more than yM alone.

In certain

The activity of antibodies with

intermediate sedimentation coefficients in man is sensitive to reduction (Rockey
and Kunkel, 1962) as is the activity of 7S antibodies in non-mammalian vertebrates
(Uhr et al., 1962b).

7S antibodies in man, rabbit, and sheep may lose complement-

fixing or sensitizing activities after treatment with 2-ME (Ishizaka, Ishizaka,
and Sugahara, 1961; Wiedermann, Miescher,and-Franklin, 1963; Schur and Christian,
1964),

Depending upon the occurrence of similar effects of 2-ME on mouse serum

proteins, the two classes of antibodies as defined by sulfhydryl inactivation
and described in this paper may include types of gamma globulin other than 19S and
7S antibodies.
4.)

OTHER PROPERTIES;

various other properties of yM and yG anti-flagej.lar

antibodies are summarized in Table III. These experiments show that neither early
nor late antisera were dependent on complement for their activity.

Also, neither

of the antibodies lost activity during the storage times before titration.
E.)

THE KINETICS OF PRIMARY RESPONSE yM and yG;

the results of 2-ME characteri-

zation of antibody type during the primary response are shown in Fig. 10. The unbroken line represents titers in untreated sera; the dotted line shows the residual titer after the sera were incubated for two hours at room temperature with
2-ME.

Each point represents the average of at least three mice, and the range

of individual titers is shown.
The response was quite similar to primary responses already described in
other species with a variety of other antigens.

Beginning, at four days after

antigen injection, there was a sharp increase in antibody susceptible to reduction

Reciprocal
Treatment of Immune Sera

5 day

Titer
15 day

dilution in saline

256

512

dilution in saline - 10% guinea pig serum

256

1024

heated 56°C : 30 minutes

128

256

0.0IK sodium-EDTA

128

512

untreated: 2 hrs. room temperature

256

512

8

256

O.ll-i niercaptoatbanol: 2 hrs. room temperature
frozen-t:bawed: 5 Limas

—

512

-15 C ; two weeks

256

---

4°C ; five days

256

1024

4°C : tiwo weeks

128

512

Table III

Various treatments of early and late primary antisera.
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by 2-ME.

The production of this yM antibody was very short-lived and

apparently ceased between day 7 and day 10. By subtracting titer values of
untreated and 2-ME-treated antisera, yM could be estimated to decline after
day 10 with a half-life of 24-48 hours. This is in fair agreement with the mean
biological half-life of passively administered yM anti-0X (Uhr and Finkelstein,
1963).
Three days after the first appearance of yM in the serum, antibody
that was resistant to 2-ME reduction first appeared.

At the antigen dose used,

the rate of increase of this yG antibody was relatively slower than the rate
of increase of yM.

No attempt was made to study the effect of dosage on the

rates of formation of either antibody.

By day 20, yG accounted for all the

antibody activity present and was declining with an approximate half-life of
6-7 days.
F.)

THE EFFECT OF SPLENECTOMY;

there have been many studies suggesting that

the early antibody in a primary response is derived from the spleen and that later
antibody is produced in the lymph nodes and bone marrow (Taliaferro and Taliaferro,
1950; Benedict et al., 1962; Svehag and Mandel, 1964a).

Such evidence, as well

as studies on the cessation of macroglobulin antibody synthesis after splenectomy
in dysgammaglobulinemic patients, led Rosen (1962) to suggest that "l9S gammaglobulin production occurs principally in the spleen." On the other hand, Askonas,
Humphrey, and Porter (1956) suggested that the spleen produces antibody late in
the response, not early, and Davidsohn, Lee, and Zandrew (1964) reported that
splenectomy removes the ability to produce yG, not yM

From the studies with

spleen homogenates above and from other reports (Asofsky and Thorbecke, 1962;
Chiappino and Pernis, 1964), there seemed little doubt that the spleen could
produce both yM and yG antibodies; however, the relative production of these
types by the spleen as compared with the rest of the body had not been established.
This was studied indirectly by utilizing splenectomized mice.
Mice were splenectomized and allowed to recover fully from the effects of
the operation before antigen injection.
the same response as normal animals.

Sham-operated animals consistently gave

The response in the splenectomized animals

is seen in the lower half of Fig. 11. The serum titers in these mice were much
reduced below the normal response levels. Early samplings were not frequent enough

to determine whether there were "minor differences in the time of antibody appearance
or in the rate of increase in the serum between the operated and intact mice.
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The effect of splenectomy on the relative production of yM
and yG antibodies.
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It seemed clear, however, that splenectomy had equally depressed both types of
antibody without altering the amount of one relative to the other in the serum
during the first 20 days.

At any time point, the ration of yM to yG was the

same in splenectomized as in intact mice.

The experiment did not answer the

question of whether the spleen produced antibody relatively early or late in
the response.

It did show that the spleen not only produced both types of

antibody, but also produced them in the same proportion as extra-splenic
sources.
G.)

INHIBITION OF THE PRIMARY RESPONSE;

1.)

USE OF METHOTREXATE;

in the effort to determine the nature of the yM-yG

transition and possibly to investigate the cellular basis of production of each,
some attempts were made to dissociate the two kinds of antibody in a primary
response,

Turk and Stone (1963) reported that methotrexate administered I.P.

to guinea pigs failed to inhibit the production of large pyroninophilic cells
in the lymph node draining a sensitized ear; the methotrexate did, however,
block the development of plasma cells.

It thus seemed possible to use this

drug to investigate the relationship of haemocytoblasts and plasma cells to
yM and yG antibody production.
Various doses of methotrexate were given to mice to determine the inhibition
of the immune response (Fig. 12). In this figure and those to follow, the arrows
below the abscissa indicate the days on which methotrexate was administered.

The

amounts indicated were the daily doses given to each mouse and all injections
were intraperitoneal.

At least three mice were sacrificed at each time point.

When methotrexate was given every 48 hours throughout the response, doses
of 2 mg/kg depressed serum titers while doses of 20 mg/kg totally inhibited the
immune response.

The weight gain or loss was determined as an indication of the

general health of the animals (Fig. 13). With 2 mg/kg all the mice looked
normal and gained weight as fast as normal or antigen injected controls. This
dose

could be used throughout the response.

On the other hand, 20 mg/kg given

every 48 hours caused mice to lose weight rapidly.
and 50% usually died within 10 days.

The mice were outwardly sick

This dose was therefore used only for

short periods.
The primary yM and yG responses obtained when low doses of methotrexate
were given every other day are shown at the top of Fig. 14. The. mice varied in
sensitivity to the drug causing a wide spread in titers at some points. Also,

Dose-response

Methotrexate

_,^_ 0.2 mg/kg
^Norm.

Fig. 12

Inhibition of the primary response by different doses of
methotrexate.

Days after antigen

Fig. 13

Weight changes in mice receiving methotrexate.
A)

normal control mice

B)

mice receiving methotrexate only

C)

antigen control " no methotrexate

D)

methotrexate started at the time of antigen injection

E)

methotrexate started 18 hours after antigen injection
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the mice used in these experiments were unaccountably somewhat less sensitive
to methotrexate than the mice used in the dose-response curve. Nevertheless,
the features described below were confirmed in repeated experiments and were
also true of a number of different doses and administration schedules which
will not be discussed.
Methotrexate given in sub-inhibitory doses throughout the response
did not affect the onset or amount of yM production:

there was a substantial

titer at five days, reaching a maximum at 7-10 days, and yM disappeared by 20
days.

The onset of yG production, however, was delayed 3-5 days.

Yet despite

continued administration of the drug, the yG did appear in the serum, increased
at its normal rate, and reached its normal peak titer which it maintained when
followed for two additional weeks.

The two features of this response, the apparent

greater sensitivity of yG synthesis to methotrexate and the invariable total recovei
of yG synthesis, were typical of a number of different experiments.
The bottom graph in Fig. 14 shows that the timing of dose administration
was as important as the amount given.

The yM response was delayed 2 days, in

this case, by simply giving the first two injections of methotrexate closer
together.

The following yG response seemed to be little different than the yG

in the top half of the figure.
When doses of 2 mg/kg were given every 48 hours for 12 days preceding
antigen injection and were stopped before antigen was given, or when doses were
not begun until day 8 of the primary response there was no effect on the onset
or peak titer of either yM or yG. Apparently, the events in antibody formation
vhich were sensitive to methotrexate at this dosage occurred between the time of
administration of antigen and day 7.
It should be noted that the delay in yG antibody did not prolong the yM
antibody response or seem to affect the rate of yM decline.

The mechanism for

terminating yM production seemed to be independent of the presence or absence
of normal levels of yG.
The effect of a ten-fold increase in methotrexate dosage on the immune
response was investigated.

Because a single injection failed to noticeably inhibit

either yM or yG, it was necessary to give at least 3 separate doses in the space
of four days.

A comparison of the two experiments in Fig. 15 shows the extremely

different results obtainable with different injection schedules. The top graph
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is similar to experiments with 2 mg/kg except that both responses are more
depressed.

In the bottom graph, a shift of one day in each injection has caused

the yM response to be almost totally inhibited.

It was most interesting that in

the latter case the yG response was little different from the yG response in the
upper graph.

Apparently, the near absence of a detectable yM response did not

alter the recovery of yG production.
The last experiment in this series (Fig. 16) is included to emphasize that
inhibition of either yM or yG involves interruption of some sensitive step in the
inductive period and is not the result of general inhibition of protein synthesis.
Large doses of methotrexate given every other day starting at day 8 failed to
accelerate the decline of yM or to inhibit yG production and the eventual recovery
of normal yG titers.
2.)

USE OF COLCHICINE;

colchicine was found to depress ,the immune response in
li

animals given only one dose intraperitoneally.

It was decided to use colchicine

in an effort to pinpoint the inhibition-sensitive periods in the yM and yG
response.

Although known primarily for causing metaphase arrest, colchicine

has too complex an effect in vivo to conclude that its inhibition of either
yM or yG results from inhibition of cell division alone.

The biochemical sites

of inhibition are probably different in the case of colchicine from that of
methotrexate.
Despite the differences in the two drugs, the effect of colchicine on yM
and yG production was strikingly similar to results found with methotrexate
(Fig. 17). A single injection of colchicine given on day 4 was able to delay
the yG response to roughly the same degree as seen with methotrexate.

yG synthesis

again seemed able to recover substantially from this inhibition and to regain
near-normal titers. After colchicine was given on day 4, the titers of yM on
the following day were higher than normal.

This possibly was the result of

immediate cell damage caused by the colchicine and the consequent release of
antibody.

Perhaps because of such cell damage, the yM in the serum was lower

than usual on day 10.
When colchicine was given on day 1, yM was sharply reduced in almost
all subsequent samples.

The large range of titers shows that a few mice were

not as sensitive as most others to;this dose. Although the yG response was more
delayed than in the upper graph, the experiment tended to reinforce the evidence
from the methotrexate studies that the fate of the yG response was independent
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of the presence of a preceding yM response.

Since the yG response recovered to

near normal levels, cell destruction was probably not involved in this colchicine
effect.
H.)

HISTOLOGICAL STUDIES;

the experiments on inhibition were prompted by

Turk's contention that methotrexate stopped the maturation of haemocytoblasts
to mature plasma cells in guinea pigs.

It was therefore of interest to examine

the delay and eventual recovery of the yG response in the light of simultaneous
cellular events.

In the discussion below, the histological response in antigen-

injected controls will be discussed only briefly since it has already been described in the "introduction."

The methotrexate-treated animals are represented

by the graph in the top half of Fig. 14. Spleens were removed at the times of
sacrifice for serum antibody determinations.

Representative sections from

antigen controls and methotrexate-treated mice are shown in Figs. 18-26.
1.)

THE CELLULAR RESPONSE TO S. ADELAIDE;

all spleens showed sharp distinctions

between red and white pulp with both hematoxylin-eosin and methyl green-pyronin
staining.

By day 6 of the primary response there were numerous secondary nodules

in the follicles.

These nodules were distinct from the rest of the white pulp

and consisted of many large mononuclear cells with large, pale, central nuclei
and thin, bright rims of pyroninophilic cytoplasm.
"starry sky" appearance.

A few nodules already had a

These same large, pyroninophilic cells were found along

arterioles in the white pulp, at the border, and leading into the red pulp.
was some aggregation of cells in the red pulp.

There

By day 10, the secondary nodules

had enlarged and still consisted of large, haemocytoblast-like cells. Tingiblebody macrophages were evident in almost all nodules.

In the red pulp, there

were distinct aggregates of pyroninophilic cells, many large and medium sized, along
with many typical, mature plasma cells.

On days 16 and 21, the nodules remained

prominent in the white pulp. Aggregates of mature plasma cells were present throughout the red pulp.

The response in these antigen controls was quite typical and

somewhat longer-lived than responses to soluble antigens in the absence of endotoxin
2,)

THE CELLULAR RESPONSE DURING METHOTREXATE ADMINISTRATION;

spleens taken on

day 6 after antigen injection had a light-stained appearance in sections due to
the depletion of lymphocytes in the red pulp.
the red and white pulp was very indistinct.

In many mice the boundary between

There were no secondary nodules in

most follicles.

In a very few follicles a cluster of some pyroninophilic cells

could be found.

These consisted of only a very few cells having the appearance of

Fig. 18

Day 6.

Antigen control (X 100)

Many secondary nodules can be seen in the white pulp
Cell aggregates are evident in the red pulp.

Fig. 19

Day 6.

Antigen control (X 310)

Haemocytoblasts are clustered throughout the white
pulp and along the edge of the arteriole.

They are

characterized by large, pale blue, central nuclei
and thin rims of brightly pyroninophilic cytoplasm.
The secondary nodule is well defined from the surrounding white pulp. A few "tingible body" macrophages
are seen as white areas with dark inclusions. The
aggregated cells in the red pulp are mostly immature
plasma cells.
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Fig. 20

Day 10. Antigen control (X 255)
Secondary nodules in the white pulp have enlarged
and are surrounded by distinct cuffs.

Large agg-

regates of plasma cells are seen in the red pulp.

Fig. 21

Day 16, Antigen control (X 100)
Nodules are well defined with the typical starry sky
appearance.

They are found in almost all white pulp

follicles.

Aggregates in the red pulp are distinctly

separated and consits of typical mature plasma cells.
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Fig. 22

Day 6.

Methotrexate treated (X 100)

Red pulp is severly depleted of cells and white pulp
only stains lightly.

There are no secondary nodules,

haemocytoblasts, or cell aggregates evident. A number of cells with pyknotic nuclei are present along
the edges of the arteriole.

Fig, 23

Day 10, Methotrexate treated (X 255)
Many haemocytoblasts are seen in the red pulp. The
cells are not aggregated.

None of these cells are

found in the white pulp, and no secondary nodules
are evident.

Fig. 24

Day 16. Methotrexate treated (X 255)
The red pulp pyroninophilia has diminished but is
still present.

There are still no haemocytoblasts

or secondary nodules in the white pulp.

Fig. 25

Day 10. Antigen control (X 950)
The aggregated cells in the red pulp are typical
mature plasma cells.

Fig. 26

Day 16, Methotrexate treated (X 950)
Red pulp. The cells are typical haemocytoblasts
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haemocytoblasts.

Cells with pyknotic nuclei were clustered in the white pulp

and were often found around arterioles in the red pulp.
philic.

These were not pyronino-

On the whole, pyroninophilic cells were quite scarce.

found in the red pulp.

Some could be

These were large, mononuclear cells.

Day 10 sections from treated mice showed the red pulp filled with pyroninophilic cells. Many were clustered around arterioles and under the capsule, but
they were not arranged in striking aggregates as they were in control animals.
These cells appeared to be haemocytoblasts.

Only an occasional follicle contained

anything resembling a secondary nodule. When seen, these consisted of only a few
pyroninophilic cells.

No mature plasma cells were evident.

By day 16, the pyroninophilia was much less marked in the red pulp.
Some pyronin-stained cells under the capsule seemed to have no structure and
looked dead.

There were areas of the red pulp which contained large, pyroninophilj

cells, but these were still not distinctly aggregated.

Mature plasma cells and

secondary nodules could neither be found at this time nor at day 21.
The distinctive differences between the methotrexate-treated and control
animals were the absence of secondary nodules in the white pulp, the lack of

distinct aggregates in the red pulp, and the failure to develop mature plasma cells
in all animals receiving the drug.

The possible importance of these differences

will be discussed below,
I,)

THE TRANSFER OF yM AND yG PRODUCTION:

there have been many theories that the

yM-yG transition in some way depends on intimate cell relationships in situ or on
the presence of antigen late in the primary response. Many of these theories have
been discussed in the

Introduction".

The transfer of primed spleen cells to X-

irradiated recipients seemed a possible means of exploring these questions.

In

effect, the separation of the cells at the time of transfer would disrupt and rearrange any existing cellular relationships.

The washing of the cells would

probably remove any extracellular antigen.
Donors were immunized with S. adelaide and their spleens were removed 2,
6, 8 and 10 days after antigen.

The cells were separated, washed, resuspended,

and injected into recipients as described in "Materials and Methods." With the
technique used, it was impossible to obtain all the cells in any spleen. The
number of cells injected into each recipient was approximately one-half the number
of cells usually extracted from a spleen, and this number corresponded to one-half
or one-third

the number of cells obtained from a comparable mouse spleen by
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Jerne (Jerne, Nordin, and Henry, 1963).
The results of the transfer of cells taken early in the primary response
are shown in Fig. 27. When cells were transferred two days after antigen only
yM was produced in the recipients; cells transferred on day 6 produced convincing
titers of yM but barely detectable levels of yG.

When cells were transferred on

day 8 or day 10, however, there was very little yM in the recipients, but quite
high titers of yG were detected (Fig. 28).
It was necessary to control these experiments in a variety of ways.
In the first place, it was possible that the recipients had recovered from the
X-irradiation and were producing antibody in response to antigen transferred with
the cells. When antigen was given to mice 24 hours after X-irradiation, however,
these mice never produced detectable serum antibody titers within 12-14 days after
antigen. Additional controls employed frozen and thawed cells taken on the second
day after antigen. When these cells were injected into either X-irradiated recipients or normal mice no subsequent antibody titers could be detected.

Apparently

there was not enough antigen transferred with the cells to stimulate antibody
production even in normal mice.
Secondly, the experiments were open to the objection that the cells transferred on days 2 or 6 had simply died after a short time in the recipient and
released the antibody which they contained.

It is unlikely, however, that no yG

was produced in these responses because the transferred cells were dead.

In the

first place, X-irradiated recipients are known to-provide good cultural conditions
for transferred cells. Also, in these two cases, no antibody could be detected in
the recipients until at least four days after transfer, so the cells did not die
immediately.

The transferred cells were 85-907o alive as measured by trypan blue

staining at the time of transfer.

In addition, the previous studies in this paper

on homogenization of spleens showed that at the times of transfer the spleens did
not contain enough antibody to passively immunize the recipients to the extent
shown.

Finally, the half-life of passively administered yM antibody is known to

be relatively short, and it is unlikely that small amounts of passively transferrec
yM anti-body would continue to be detectable in the recipient seruin for as long as
15 days after the day of transfer.
From these studies, it would seem possible to conclude that 1) the events
necessary in the immunized donor for yG synthesis had not yet been completed by
day 6 after antigen, that 2) the cells producing yM were no longer dependent on
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Fig. 27

The transfer of yM production by primed cells taken early in

a response. The arrows indicate the day of transfer.
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The transfer of yG production by cells taken late in a
response.

The arrows indicate the day of transfer.
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extracellular antigen or nearest-neighbor cell relationships after day 1,
that 3) yM production had ceased in the donor by day 8 but not before day 6,
and that 4) yM production was prolonged past its normal shut-off time by transfer
to recipients on day 6.
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IV. DISCUSSION
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The findings that two types of antibodies were involved in the primary
response raised the possibility that these antibodies were produced either by
different organs, by different cell lines, or sequentially by the same cell.
The experiments in this thesis were aimed indirectly at answering which of these
possibilities was more probable. Attempts were made during the course of this
study to assay directly the production of either yM or yG by different types of
cells (employing bacterial adherence to cells in vitro), but the cellular types
proved difficult to identify consistently or with certainty, and no conclusions
were reached.

Although the present experiments have not solved the one cell-two

cell controversy, they have clarified in some ways the relationship of the yM to
the yG response, they have oescribed some of the factors which can alter the yMyG transition, and they have raised many questions which should be open to further
experimentation.
The early experiments in this study dealt with the role of the spleen in
the formation of yM and yG antibody.

The results of spleen homogenization were

consistent with the conclusions of Asofsky and Thorbecke (1962) and Chiappino
and Pernis (1964) that the spleen produced both yM and yG.
The distinct separation of the two antibody peaks gave some evidence that
yM production ceased relatively early in the response.

There was probably an

overlap of these peaks which was not detected because of the low levels of activity.
Nevertheless, the peak titer of yM in the spleen occurred on day 5 and none was
found by day 8.
These studies did not, however, provide an^ evidence about the relative
quantities of each type of antibody produced by the spleen.

It was still possible

that one type of antibody was primarily associated with the spleen and another
with lymph nodes or with bone marrow.

In vitro culture of a primed organ might

have established the quantitative relations desired, but one could never be sure
that differences in the quantities of yM and yG produced were not reflections of
preferential cell survival under the conditions of culture or were not caused by
the removal of the organ from various circulatory factors.
were therefore pursued.

Indirect experiments

There seemd to be little doubt that under these conditions

removal of the spleen prior to antigen administration did not influence the relative
proportions of yM to yG.

What appeared to be a lack of yG at day 7 probably re-

sulted from the inability to detect the generally lower titers at that time. It
would seem that antibody producing organs are equally capable of producing yM and
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yG antibodies.

This conclusion appeared reasonable, since studies by other

investigators had employed foot pad injections to evoke typical yM-yG responses.
A foot pad injection would involve primarily the draining node while an intravenous injection would involve primarily the spleen.

Yet the responses summarized

in Table I are generally all the same.
This conclusion is contradicted by the report of Davidsohn et al. (1964);
however, the use of erythrocytes as antigens might make that report a specialized
case.

The antigen used by these authors as well as their method of titration is

known to favor the production and detection of yM antibodies. With red blood
cells, many injections must be given in order to stimulate yG production.

This

may be due to the inability of this antigen to reach antibody forming cells in
doses above the yG threshold (see p. 14 of this thesis).
probably accentuate the antigen distribution problem.

Splenectomy would

In the absence of the

spleen, more antigen would be trapped by the liver which apparently destroys
the immunogenicity of erythrocytes (Franzl, 1962).
One word might be added about the bimodal spleen weight curve and its
similarity to the curve of antibody content.

This result was surprising since

there was no correlation between the weight of a spleen and its antibody content.
Very little is known ab©ut the rate of secretion of antibody from the spleen, so
that assays of homogenates may give only a rough index of splenic antibody synthesis.

It was of interest, therefore, to find that Wust and Novelli (1962) had
14
studied the incorporation of C -glycine into spleen and liver protein after
antigen injection. These authors found a distinctly bimodal curve of incorporation
into spleen protein with the first peak on day 5 and the second peak on days 10
and 11, These authors felt that the increase in spleen weight was caused by
increased protein synthesis. No reason was offered by them as to why the incorporation curve was bimodal or what its relationship was to antibody production or
cell division.
The experiments with methotrexate suggested that the yG response was more
sensitive to inhibition than yM,

It was difficult, however, to visualize what

this meant in terms of the.action of the drug or what it implied about the cells
involved.

Methotrexate is known to inhibit the conversion of folic acid to

tetra-hydrofolic acid; a derivative of this latter compound is needed as a cofactor for DNA synthesis.

The principal action of the drug is therefore to inhibit
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DNA metabolism and consequent cell division.

Less is known about the in vivo

action of colchicine, but it is likely that metaphase arrest occurred and
division was inhibited.

Nevertheless, little could be said about the action of

these drugs in terms of the site of inhibition of the immune response. Arrest
of cell division or inhibition of cell differentiation and maturation may have
been equally responsible for the results obtained here.

It was difficult to

determine the most sensitive times in the response to methotrexate. At best,
it was possible to show that pretreatment with the drug or treatment after day 8
did not inhibit serum levels of antibody.

The experiment shown in the bottom

half of Fig. 14 suggested that on the first day after antigen administration
antibody producing cells might be especially liable to inhibition by methotrexate.
This possibility was consistent with the results of colchicine inhibition: a
single dose of colchicine given on day 1 was more effective at inhibiting both
yM and yG antibodies than a single dose given on day 4.

So it may be that the

most sensitive periods of both responses occur early in the response.

The 24-48

hour period after administration of antigen is known to be the time of maximum
cellular proliferation.

That yG synthesis is still sensitive to colchicine in-

jection on day 4 while yM is apparently not inhibited may be interpreted to mean
that cell division and/or differentiation must occur late in the response for yG
production to proceed.
No firm evidence was obtained about whether one cell or two major cell
lines were involved in producing yM and yG, The two responses appeared to be
independent:

delaying the yG response did not affect the rise or subsequent

decline of yM, while inhibition of yM did not affect the eventual recovery of
yG.

Such evidence encouraged but did not prove a conclusion that two cell types

were involved.
The histological studies reinforced this hypothesis. At early times in
the response of methotrexate-treated animals, yM levels were near normal yet
there were no collections of haemocytoblasts in the spleen, and there were only
a very few pyroninophilic cells in both the red and white pulp.

No conclusion

could be made about the cell responsible for the yM production in these experiments.

On the other hand, the dramatic increase of haemocytoblasts in treated

animals on day 10 was clearly correlated with the concurrent rise of yG in the
serum.

This evidence might suggest that yM can be produced by a cell not commonly
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associated with yG production (other than the haemocytoblast-immature plasma
cell - mature plasma cell line).

It does not suggest what that cell might be

nor does it claim that yM is not produced by these latter cells as well as yG.
The yM cell might, of course, transform into one of these pyroninophilic cells,
in which case two cell lines would not be involved.
The histological studies were also of interest during the recovery of
yG synthesis.

They showed that the formation of mature plasma cells, the anatomical

grouping of these cells into the classical "aggregates," and the establishment of
secondary nodules were not essential to the recovery of the yG response. In the
light of suggestions that the secondary nodules are the sites of immunological
memory, it would be of interest to see whether these methotrexate treated
animals, which recover yG production but do not produce nodules, could be
stimulated to produce a typical secondary response.
It has been suggested (Finkelstein and Uhr, 1964) that yM synthesis is
transitory during a primary response because of a "feedback" mechanism exerted
by the presence of yG antibody.

These authors assume that the mechanism of this

feedback is the capture of antigen by the yG molecules.

Previous studies by

these same authors (Uhr and Finkelstein, 1963) and by others (Svehag and Mandel,
1964b) suggested that the duration of yM synthesis was dependent on a persistent
supply of antigen.

There has been no evidence provided, however, concerning the

antigen source or the localization of the hypothetical yG-antigen interaction.
With regard to this feedback theory, two observations seemed pertinent.
In the first place, the yM response followed its normal course in those methotrexate
experiments where the yG response was delayed.

This was not consistent with a

theory in which the increase in yG is responsible for inhibiting yM.

Secondly,

when cells were transferred to X-irradiated recipients on day 6 after injection
of antigen the yM synthesis apparently continued for at least 15 more days.
The continuation of a yM response in the absence of yG synthesis seems to support
a feedback mechanism.

The key to a feedback theory, however, is the availability

of antigen to the yM-forming cell.

Where does this antigen come from in the

recipient to stimulate yM for 15 days?' The transfer experiment would indicate
that the source of the antigen is neither extracellular nor dependent on the
maintenance of the original "anatomical continuity between reticuloendothelial
cells and lymphoid cells" as suggested by Finkelstein and Uhr (1964).

If antigen
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is required for continued yM synthesis, it is either in the yM-forming cell
itself or one must postulate the re-establlshmentof the previous intimate cell
relationships so that, let us say, macrophages can "feed" antigen to surrounding
lymphoid cells.

The latter event seems unlikely.

that the antigen source is within the yM cell.
interaction?

Let us assume for a moment

Where then is the yG-antigen

Is it within the cell or at its surface?

Is the interaction toxic

to the cell? Why is yM ineffective at inhibitibn?
The present experiments have suggested that the site of yG-antigen
interaction is the yM producing cell and not the reticuloendothelial phagocyte.
This suggestion is open to experimental investigation.
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During the course of the experiments reported here, a number of studies
were made of the secondary response.

They have not been reported in this thesis

because we could not demonstrate a yM response preceding the large yG response.
The studies included, however, experiments on the localization of antigen similar
to those experiments conducted

during the primary response.

The results of

these localization experiments are included here so that the effect of circulating
antibody on the fate of these bacteria can be seen.
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